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Abstract 
The highly conserved mitogen activated protein kinase (MAPK) high-osmolarity 
glycerol (HOG) pathway plays a vital role in the ability of Saccharomyces cerevisiae 
cells to respond to stress conditions, primarily hyperosmotic stress. In addition, there is 
also evidence that the HOG pathway is involved in lipid accumulation, which occurs in 
nitrogen depleted cells as they enter stationary phase. Understanding this lipogenic 
switch is important both for the biotechnology industry (for example biofuels) and 
understanding human disease, where cancer cells accumulate cellular lipid.  
 
To investigate the role of the HOG1 pathway in neutral lipid accumulation, a Nile red 
assay was undertaken to measure lipid accumulation in stationary phase of genomic 
deletion strains of key HOG pathway proteins. Deletion of the majority of HOG 
components had no effect on lipid accumulation. However, the hog1Δ mutant showed a 
significant decrease in neutral lipids levels when compared to the wildtype. Hog1p is 
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the key MAPK in the HOG pathway and this data suggests that it may also be a 
regulator of neutral lipid accumulation.   
 
Hog1p is activated by phosphorylation, as such, a western blot analysis was performed 
to monitor dual phosphorylation of Hog1p during the lipogenic switch. This showed an 
increase in Hog1p phosphorylation between 9 – 10 hours of growth, which corresponds 
to the transitionary period between late exponential phase and early stationary phase 
and accumulation of neutral lipids. 
 
Regulation of Hog1 is classically believed to be via dual phosphorylation by the 
MAPKK Pbs2. However, results from the Nile red assay of the pbs2Δ mutant, 
demonstrated that accumulation of neutral lipids is not affected in this strain when 
compared to the wildtype. Further, a hog1Δpbs2Δ double deletion showed no additive 
affect when compared to the individual deletion strains. This suggests that Pbs2p is not 
involved in the accumulation of neutral lipids, and, therefore, Hog1p is being activated 
by an alternative regulator. This was further investigated by monitoring Hog1p 
phosphorylation during the lipogenic switch in the absence of Pbs2p. 
 
To investigate how Hog1 is regulating lipid accumulation, a number of potential neutral 
lipid downstream targets were investigated. One potential target is Dga1p, an enzyme 
that catalyses the terminal step of triacylglycerol formation in lipid production. Deletion 
of this protein results in reduction in neutral lipid levels as measured by the Nile red 
assay. A similar reduction in neutral lipid levels was observed in a hog1Δdga1Δ double 
deletion indicating the proteins may be involved in the same pathway. Dga1 being a 
target of Hog1 is supported by bioinformatics analysis, which identified four potential 
MAPK sites (S/T followed by P) within the protein.  
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This work indicates a potential novel role for Hog1p in regulating lipid accumulation in 
S. cerevisiae which may have wider implications for the study of lipid related diseases 
and for the biotechnological application of cellular lipids. 
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1. Introduction 
 
1.1 Cancer 
Cancer is a disease state of cells in the body in which cells undergo uncontrolled 
proliferation. Irrespective of the cause, the result is cellular genetic changes leading to 
the acquisition of certain characteristics (hallmarks of the disease) that define cancer 
(Hanahan  and Weinburg 2011). 
 
In normal tissues, cellular growth is tightly controlled. Growth promoting signals and 
cell cycle checkpoints, which control entry and progression though the cell cycle, are 
key components in this regulation. Cancer cells can avoid these regulatory 
mechanisms, via a series of methods including overexpression of intracellular 
pathways and mutation of key proteins, resulting in uncontrolled cell proliferation 
(Hanahan and Weinburg 2011). 
  
Another key characteristic of cancer cells is their altered metabolism, which results in 
cells accumulating more lipid and undergoing aerobic glycolysis, due to the Warburg 
effect (Warburg 1925; Warburg 1956; Diaz-Ruiz et al 2011; Walther  and Farese 2012; 
Baenke et al 2013; Liberti et al 2016). This altered metabolism provides the cancer 
cells with both energy and increased lipid synthesis required to support their 
proliferation with many cancers undergoing increased de novo fatty acid synthesis 
(Esechie et al 2009; Liberti et al 2016).  
 
1.2 Signalling pathways 
 
Lipid accumulation is regulated by several signal transduction pathways (Zaidi et al 
2013). These pathways are predominantly what become dysregulated in cancer (Zaidi 
et al 2013; Sever et al 2015). Cells need to be able to by aware of their changing 
environment by detecting and responding to external stimuli to survive. Cell sensing 
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and signalling pathways are the mechanisms by which the cell can respond to change 
by communicating with cytoplasmic and nuclear targets to elicit a phenotypical 
response to stimuli (e.g. the osmostress response to external salt concentrations) 
(Marshall 1994; Waskiewicz et al 1995; Lawrence et al 2007). 
 
1.2.1 AMP-activated protein kinase (AMPK) 
 
AMPK is a key pathway involved in regulating numerous cellular processes within the 
cell including lipid metabolism (Krebs et al 1979), with its deletion causing Warburg 
effect phenotype in cells (Faubert et al 2013). AMPK activation requires 
phosphorylation (primarily performed by liver kinase B1) at the threonine residue 
Thr172 within the activation loop of the catalytic subunit (Hawley et al 1996); this can 
be in response to several factors which deplete cellular ATP supplies (Hurley et al 
2006). Once activated, the AMPK pathway can perform many functions (Figure 1.1) 
such as decreasing fatty acid synthesis by phosphorylating (and so inactivating) the 
acetyl-CoA carboxylase enzymes (ACC1 and ACC2) resulting in no malonyl-CoA 
production, which is needed to produce palmitate (Jeon et al 2012). This generally 
occurs in states of glucose starvation and hypoxia, AMPK will promote the breakdown 
of fatty acids by promoting their mitochondrial uptake where they are broken down by 
β-oxidation. In cancer this process can be disrupted as intact mitochondrial function is 
required, which can be limited in cancer (Liang et al 2013).  
14 
 
 
Figure 1.1 AMPK promotes cell survival. Adenosine monophosphate-activated 
protein kinase (AMPK), acetyl-CoA carboxylase isoform 1 (ACC1), acetyl-CoA 
carboxylase isoform 2 (ACC2), peroxisome proliferator-activated receptor gamma 
coactivator 1-alpha (PGC1A), insulin receptor substrate 1 (IRS1), 6-phosphofructo-2-
kinase/fructose-2,6-biphosphatase 3 enzyme (PFKFB3), Glucose transporter 1 (GLU1), 
Tuberous Sclerosis Complex 2 (TSC2), serine/threonine-protein kinase ULK1, 
Hypoxia-inducible factor 1 (HIF1), TBC1 domain family member 4 (TBC1D4), glycogen 
synthase kinase 3 beta (GSK3β). Adapted from Liang et al 2013 
 
1.2.2 Mechanistic target of rapamycin (mTOR) 
 
mTOR consists of two separate complexes, mTORC1/mTORC2, and serves as part of 
a signal transduction pathway which is a central regulator of cell growth, proliferation, 
metabolism and survival (Laplante et al 2009a). mTOR is implicated in the regulation of 
15 
 
lipogenesis by its ability to promote activation of sterol regulatory element-binding 
protein 1a (SREBP-1a) (Porstmann et al 2008; Laplante et al 2009b) which has been 
implicated in the regulation of lipid biosynthesis (Liang et al, 2002). Once active 
SREBP-1a translocates to the nucleus where it activates SREBP responsive genes 
including include FASN (Laplante et al 2009b); FASN encodes the fatty acid synthase 
(FASM) enzyme (Jeon et al 2012; Krycer et al 2010). Figure 1.2 displays the role of 
mTOR in lipid biosynthesis.  
 
Figure 1.2. mTORC1 promotes de novo lipogenesis through the activation of 
SREBP-1. Acetyl-CoA carboxylase (ACC), acyl-CoA lyase (ACLY), fatty acid synthase 
(FASN), glycerol-3-phosphate acyltransferase (GPAT), glucokinase (GK) and stearoyl-
CoA desaturase-1 (SCD-1). Taken from Laplante et al 2009b. 
 
1.2.3 Mitogen activated protein kinases (MAPK) 
 
There are many MAPK pathways. These pathways mediate intracellular signalling that 
it associated with cellular activities including cell proliferation, differentiation, survival, 
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transformation, migration and apoptosis (Dhillon et al 2007). p38 and ERK are two 
mammalian MAPK pathways. 
 
ERK 1/2 MAPK are part of the Ras-Raf-MEK-ERK signal transduction cascade, which 
is involved in many processes including the cell cycle, and cellular metabolism 
(Roskoski 2012). This cascade is initiated by the G protein RAS (Shaul et al 2007) as 
shown in Figure 1.3. MAPKs are involved in the metabolic switch that occurs in cancer 
with implications that increased signalling via the Ras/Raf/MEK/ERK cascade leads to 
increased FASN expression (and so increased lipogenesis) via SREBP-1 (Yang et al 
2002).  
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p38 has 4 isoforms and is involved in many cellular processes such as (but not limited 
to) apoptosis, the cell cycle and in in senescence and tumour suppression (Roux et al 
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2004; Zarubin et al 2005). There is evidence to suggest that the p38 pathway is 
involved in lipogenesis, with SREBP-1c dependent genes being transcribed as a result 
of p38- and JNK-mediated phosphorylation cascades (Guijas et al 2012). 
 
1.2.4 Sterol regulatory element-binding proteins (SREBP) 
 
The AMPK and MAPK pathways interact with STEBP (Yang et al 2002; Liang et al 
2013). SREBP are transcription factors that regulate expression of genes required to 
maintain cellular lipid homeostasis (Jeon et al 2012). There are 3 SREBPs SREBP-1a, 
SREBP-1c and SREBP-2. SREBP-1a targets genes that transcribe elements involved 
in fatty acid metabolism such as FASN (Jeon et al 2012; Krycer et al 2010). Studies 
have shown the involvement of SREBP-1a and SREBP-1c in the regulation of lipid 
biosynthesis (Liang et al, 2002). 
 
SREBP-2 targets genes involved with cholesterol such as 3-hydroxy-3- methylglutaryl 
coenzyme A (HMG-CoA) reductase, which acts as a catalyst in cholesterol 
biosynthesis, acting as a rate limiting enzyme in the mevalonate pathway (Mullen et al 
2016). SREBP-1a targets both sets of genes, and so if upregulated can cause an 
increase in the expression of both sets of genes. SREBPs can be activated through the 
AMPK pathway via Phosphatidylinositol 3’-kinase (PI3K) and Akt (Protein kinase B). In 
numerous cases of cancer mutations cause Akt to become overactive and so increase 
SREBP activity (Krycer et al 2010). SREBPs are conserved between mammals and S. 
cerevisiae (Jeon et al 2012). It should be noted that S. cerevisiae uses ergosterol 
where mammalian cells would use cholesterol (van Meer et alet al 2008 
 
These signal transduction pathways are required for normal cell function, with their 
dysregulation causing a disease phenotype, such as that seen in cancer (Downward 
2003). The mitogen activated protein kinase (MAPK) and mammalian target of 
rapamycin (mTOR) signalling pathways are especially related to disease phenotype 
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due to their involvement in cell growth, motility, proliferation and survival, processes 
(Hsu et al 2011)  Dysregulation of these pathways are often involved in cancer and, as 
such, are under intense investigation (Masui et al 2012). 
 
1.3 Lipids including lipogenesis 
Lipogenesis is a highly regulated metabolic process, whereby acetyl-CoA is converted 
to fatty acids (Zaidi et al 2013). The regulatory pathways involved include the 
adenosine monophosphate-activated protein kinase (AMPK), mechanistic target of 
rapamycin (mTOR) and mitogen-activated protein kinase (MAPK).  
 
De novo fatty acids synthesis starts with the carboxylation of acetyl-CoA to malonyl-
CoA, malonyl-CoA is then used by fatty acid synthase (FAS) to form palmitate. These 
are either used as an energy store (so incorporated into triacylglycerols) or used to 
form phospholipid membranes (Ameer et al 2014).  Figure 1.4 displays lipogenesis in 
mammalian cells. 
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Figure 1.4 The process of mammalian lipogenesis. ATP citrate lyase (ACL), acetyl 
CoA carboxylase (ACC), fatty acid synthase (FAS), malic enzyme (ME), stearoyl CoA 
desaturase (SCD1), phospholipids (PL), triglycerides (TG), growth factors (GF), very-
low-density lipoproteins (VLDL), protein kinase B (AKT). Taken from Mounier et al 
2014. 
 
FAS is a multi-enzyme protein, which under normal conditions converts excess 
carbohydrate into FAs to allow for esterification to storage triacylglycerols, these can 
then be used in times of need to provide energy through β-oxidation. In cases of 
cancer, FAS is used by the cell for de novo fatty acid synthesis using excess pyruvate 
produced from glycolysis (Menendez et al 2007).   
 
1.3 Metabolic switch in cancer 
The Warburg effect is a metabolic change that occurs in cancer cells (Warburg 1925; 
Warburg 1956). It results in what is known as “aerobic glycolysis” with cells primarily 
undergoing glycolysis despite ample oxygen; normally glycolysis only becomes the 
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primary energy source under anaerobic conditions; resulting in the production of lactic 
acid (Hanahan et al 2011). The prevailing theory behind the rational for this change, 
and why it is viable for cells despite being far less efficient an energy source when 
compared to oxidative phosphorylation (Hanahan et al 2011), is that cells redirect 
glycolytic intermediates into other synthesis pathways (Heiden et al 2009) allowing 
cells to produce the macromolecules and organelles needed for the rapid proliferation 
of cancer cells. This theory is supported by evidence that some rapidly proliferating 
embryonic cells display a Warburg-like metabolism (Hanahan et al 2011). 
 
The mechanism of de novo fatty acids synthesis (Figure 1.4) explains the need for 
cancer cells to produce high level of NADPH and comparatively less ATP (Liberti et al 
2016). In order to produce the large amounts of lipids (phospholipids and triglycerides) 
required, the FAS enzyme needs to synthesise palmitate from acetyl CoA and malonyl 
CoA, which requires NADPH (Figure 1.4). Palmitate is a synthetic intermediate in 
lipogenesis and its formation acts as the rate limiting step in de novo fatty acids 
synthesis (Ameer et al 2014). 
 
As lipid accumulation does not occur in most healthy mammalian cells (adipocytes 
being a notable exception) but does occur in cancer cells (Walther  and Farese 2012), 
understanding the metabolic differences that contribute to this change will allows us to 
better understand cancer progression. This may enable us to develop ways to prevent 
it from happening (e.g. inhibitors of a particular protein) or target the altered 
metabolism (e.g. target lipid accumulation itself) (Vander Heiden 2011; Sun et al 2014). 
This is especially of interest in cancers that are difficult to remove via surgery, such as 
gliomas (Yang et al 2013). 
 
1.4 Neutral lipids  
Neutral lipids are lipid molecules that lack charged groups (and so are hydrophobic) 
and do not form part of the phospholipid bilayers of the cell, instead forming lipid 
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droplets and lipid bodies (Czabany et al 2007). Neutral lipids can be divided into three 
groups, triacylglycerols (TAGs), steryl esters (SEs) and wax esters (WEs), with TAGs 
and SEs being the most common neutral lipids in yeast and mammalian cells, acting as 
energy stores within the cell (Athenstaedt et al 2006).  
 
Due to their hydrophobic nature, combined with the high water content within the cell, 
neutral lipids form the core of lipid droplets, with phospholipids surrounding the neutral 
lipid core (Athenstaedt et al 2006). Figure 1.5 details TAGs synthesis.  
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Figure 1.5 TAG metabolism via different pathways (Athenstaedt et al 2006). In the 
upper part of the figure, enzymatic reactions leading to the synthesis of 
diacylglycerol(DAG) via the intermediate phosphatidic acid (PtdOH) are shown. The 
framed, lower part of the figure shows the different possibilities for the final reactions 
yielding TAG. Enzymes: 1-acyl-GrnP R, 1-acyldihydroxyacetone phosphate reductase; 
1-acyl-Gro3P AT, 1-acyl glycerol-3-phosphate acyltransferase; DGAT, diacylglycerol 
acyltransferase; GrnP AT, dihydroxyacetone phosphate acyltransferase; Gro3P AT, 
glycerol-3-phosphate acyltransferase; PAP, phosphatidate phosphatase; PDAT, 
phospholipid:diacylglycerol acyltransferase; PL C, phospholipase C; PL D, 
phospholipase D; TGL, triacylglycerol lipase. Substrates: 1-acyl-GrnP, 1-acyl 
dihydroxyacetone phosphate; 1-acyl-Gro3P, 1-acyl glycerol-3-phosphate; DAG: 
diacylglycerol; FA, fatty acid; GrnP, dihydroxyacetone phosphate; Gro3P, glycerol-3- 
phosphate; MAG, monoacylglycerol; PL, phospholipid; PtdOH, phosphatidic acid; TAG, 
triacylglycerol. Diagram taken from Athenstaedt et al 2006. 
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1.4.1 Lipid Droplet formation 
While previously thought to be nothing but energy stores, lipid droplets are in fact 
involved in many functions in lipid metabolism and the production of energy (e.g. with 
the peroxisome via peroxisome protrusions which extend from the peroxisome to the 
core of the lipid droplet) (Beller et al 2010). Several models of lipid droplet formation 
have been proposed. For example, the Lensing model where neutral lipids are 
deposited between endoplasmic reticulum (ER) membrane leaflets. Once enough lipid 
has accumulated this lipid core pushes outwards and releases from the ER, 
surrounded by the phospholipids from the ER which encapsulate the hydrophobic core 
(Martin et al 2006). Other methods have also been suggested including the “bicelle” 
and “vesicle-budding” models, although there is little evidence to support either of 
them, (Wilfling et al 2013). The bicelle model is similar to that of the lensing model but 
rather than a single layer of phospholipid membrane forming the monolayer of the lipid 
droplet both layers do (Ploegh 2007). This would leave holes in the ER membrane, 
comprising the ER membrane (Walther  and Farese 2009).   
 
The “vesicle-budding” model proposes that lipid droplets form within a bilayer vesicle 
which remains attached to the membrane of the ER, lipids accumulate within the 
vesicle, filling the space between the two membranes. This squeezes the lumen of the 
vesicle and results in the membrane bulging outward from the ER membrane similarly 
to that of the lensing model (Walther  and Farese 2009). 
 
1.5 Use of yeast as a model organism 
 
The budding yeast, Saccharomyces cerevisiae (S. cerevisiae), is an excellent model 
organism as the S. cerevisiae cells are easily grown in low cost media (relative to 
mammalian cells) and have a (comparatively) simple genotype/phenotype relationship 
which is well characterised. This is especially important when one wishes to study the 
consequences of inactivation or overexpression of a gene (Mager et al 2005, Botstein 
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et al 2011). As such, to understand complex processes in mammalian cells we can 
utilise model organisms which contain highly conserved pathways.  
 
S. cerevisiae has been long established as a model organism (Zhang et al 2003; Henry 
et al 2012) and has been used to increase our understanding of many cellular and 
molecular processes (Mager et al 2005); for example, much of our understanding of 
lipid biosynthesis and its regulation in higher eukaryotes was determined using yeast 
models (Diaz-Ruiz et al 2011; Schmidt et al 2013; Koch et al 2014). Also of interest the 
fatty acid synthase structure was first elucidated in yeast (Lomakin et al 2007). This is 
because many processes and regulatory elements are conserved, with many human 
genes having orthologues in S. cerevisiae (Siepel et al 2005; Hamza et al 2015), 
including components of the lipogenic, MAPK and mTOR pathways (Figure 1.2; The 
mammalian mTOR has the S. cerevisiae homologues Tor1 and Tor2) (Hay et al 
2004;Dann   and Thomas 2006; Loewith et al 2011). 
 
1.5.1 MAPK in Saccharomyces cerevisiae 
There are multiple MAPK pathways in yeast, including the pheromone, the partial 
nutrient deprivation, the hyperosmolarity, the cell wall stress and the nutrient starvation 
pathways (Chen et al 2006). The hyperosmolarity (HOG) pathway is both structurally 
and functionally conserved to the mammalian p38 MAPK pathway as shown in Figure 
1.6 (Waskiewicz et al 1995; Banuett 1998; Wagner et al 2009). 
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Figure 1.6 Conservation of the p38 MAPK pathway between mammals and S. 
cerevisiae. Adapted from Banuett, 1998. 
 
The high osmolarity glycerol (HOG) pathway is a stress response pathway which is 
activated in response to high osmolarity, citric acid, ethanol, heat shock and pH 
(Kapteyn et al 2001; Lawrence et al 2004; Saito and Posas 2012). This results in the 
activation (via phosphorylation) and translocation of the MAPK protein Hog1p to the 
nucleus where it mediates the cell’s adaptive response, acting directly or indirectly to 
cause transcription of genes. (Ferrigno et al 1998; de Nadal et al 2010). In addition to 
phosphorylating targets, Hog1p is also required for activation of stress response genes 
by recruiting RNA polymerase II to the gene promoter (Alepuz et al. 2001). 
 
It is well accepted that Hog1p is activated by Pbs2p phosphorylation, however Pbs2p 
independent activation of Hog1p has been suggested (Rodriguez-Pena et al 2010; Qi 
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et al 2005; Maayan et al 2012). Pbs2p dependent activation of Hog1p is displayed in 
Figure 1.7. 
 
Figure 1.7 The classical HOG MAPK pathway of S. cerevisiae (Rostron 2015) 
There are two main pathways which activate the MAP2K Pbs2, the Sln1 and Sho1 
pathways, this leads to the dual phosphorylation of Hog1p at residues Thr174 and 
Ty176 allowing its nuclear localisation where it then acts on transcription factors such 
as Hot1 and Msn2/4. Arrow indicate stimulation of, blunt ended arrow indicate inhibition 
of. Taken from Rostron 2015. 
 
There is evidence to suggest that a Pbs2p independent mechanism exists, although 
not one involving a direct activator. For example, there is evidence of 
autophosphorylaton of Hog1p in response to osmotic pressure (Maayan et al 2012). 
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1.5.2 Lipogenesis in Saccharomyces cerevisiae 
By changing the growth conditions of S. cerevisiae, nitrogen limitation or media 
exhaustion of nitrogen, it can be used to simulate cancer cells; primarily though the 
Crabtree effect that occurs in yeast (RodrigoDiaz-Ruiz, et al 2011). Cells are able to 
undergo aerobic glycolysis; in cancer cells this is termed Warburg effect (Warburg 
1925; Warburg 1956; Arlia-Ciommo et al 2016).  Cells also accumulate lipid in the 
stationary phase of growth in response to nitrogen limitation in the media (Henry et al 
1973; Behalova et al 1992; Natter et al 2013); performing lipogenesis (like that of 
cancer cells) accumulating lipid (Diaz-Ruiz et al 2011; Walther  and Farese2012; 
Baenke et al 2013; Natter et al 2013; Arlia-Ciommo et al 2016; Liberti et al 2016). 
 
S. cerevisiae can perform de novo fatty acid synthesis (Bessoule et al 1987), starting 
with acetyl-CoA carboxylation by acetyl-CoA carboxylase to malonyl-CoA. Elongases 
and desaturases in the endoplasmic reticulum act to elongate and desaturate the 
products in a cyclical manner resulting in the formation triglycerides and steryl esters 
(Han et al 2002; Rossler et al 2003). 
 
S. cerevisiae synthesises the same general classes of lipids found in mammals and via 
pathways with high homology to that of mammalian systems. It should be noted 
however that there are differences, specifically in the composition of lipids, the simpler 
fatty acids and the yeast’s synthesis of ergosterol where mammalian cells would 
synthesise cholesterol (van Meer et al 2008); there is also a slight difference in the 
synthesis of phospholipids with mammalian cells incorporating poly-unsaturated fatty 
acids into some phospholipids (Figure 1.8) (Carman et al 2007; Nielsen 2009).  
29 
 
  
Figure 1.8 Comparison of lipid biosynthesis and its regulation in mammals and 
yeast. Acetyl-CoA (AcCoA), malonyl-CoA (MalCoA), acetoacetyl-CoA (AceAcCoA), 
fatty acids (FAs), phosphatidic acid (PA), diacylglycerols (DAG), triacylglycerols (TAG), 
phospholipids (PL), phospholipids containing poly-unsaturated fatty acids (PL-PUFA). 
Taken from Rostron 2015. 
 
1.6 Aims of this study 
The aim of this study is to investigate the role of the MAPK pathway in the regulation of 
(tumour associated) lipogenesis using the model organism Saccharomyces cerevisiae. 
First the role of key components of the HOG MAPK pathway (Ste11p, Ssk2p, Pbs2p, 
and Hog1p) in regulating lipid accumulation was investigated. This was followed by the 
investigation of the regulation of the Hog1 MAPK in lipid accumulation following 
nitrogen limitation. Finally, potential downstream lipogenic targets (Dga1) of the HOG 
MAPK pathway were investigated, their interaction with Hog1p would suggest its 
involvement in lipogenesis regulation. 
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Based on previous work it seems likely that the HOG MAPK pathway is involved in the 
regulation of lipogenesis, and given the known function of Dga1 it is possible that these 
two proteins may interact. 
 
2. Materials and Methods 
 
2.1 Yeast strains 
  
Details of the Saccharomyces cerevisiae (S. cerevisiae) strains utilised are detailed in 
table 2.1. 
 
Strains were maintained at 4oC on agar plates, either yeast peptone dextrose (YPD) or 
yeast nitrogen base (YNB). For non wild type strains a selection media was used, 
either G418 (100 μg/ml from 1000x stock in water), NAT (1 g/ml) or YNB lacking the 
appropriate amino acids to maintain the deletion. All plates were made and maintained 
in duplicate. See section 2.1.1 for media composition.  
 
Table 2.1: S. cerevisiae strains used. Strain information for wildtype and deletion (Δ) 
strains used. National BioResource Project of the Ministry of Education, Culture, 
Sports, Science and Technology is abirritated to NBRP of the MEXT, Japan. CLL 
followed by a number is the strain collection number for the laboratory this work was 
performed in.  
Yeast  Strain Genotype Reference 
wildtype BY4741a 
(derivative 
of S288C) 
MATa his3Δ1 leu2Δ0 met15Δ0 
ura3Δ0 
Brachmann et 
al. (1998) 
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hog1Δ BY23209  
 
MATα leu2 his3 trp1 ura3 
hog1::URA3 
NBRP of the 
MEXT, Japan 
msn2/4Δ BYP23752 MATa msn2::HIS3 msn4::URA3 
ade2-1 his3-11,15 leu2-3,112 trp1-1 
ura3-1 can1-100 
NBRP of the 
MEXT, Japan 
fat1Δ BYP5648 MATa fat1::HIS3 ade2-1 leu2-1,112 
ura3-1 trp1-1 his3-11,15 can1-100 
ssd1-d2 rad3-535 
NBRP of the 
MEXT, Japan 
pbs2Δ Y07101 BY4741; MATa; his3Δ1; leu2Δ0; 
met15Δ0; ura3Δ0; pbs2::kanMX4 
Euroscarf 
dga1Δ Y02501 BY4741; MATa; his3Δ1; leu2Δ0; 
met15Δ0; ura3Δ0; dga1::kanMX4 
Euroscarf 
ste11Δ Y05271 BY4741; MATa; his3Δ1; leu2Δ0; 
met15Δ0; ura3Δ0; ste11::kanMX4 
Euroscarf 
lro1Δ Y05383 BY4741; MATa; his3Δ1; leu2Δ0; 
met15Δ0; ura3Δ0; lro1::kanMX4 
Euroscarf 
sch9 Δ CLL130 BY4741; MATa; his3Δ1; leu2Δ0; 
met15Δ0; ura3Δ0; sch9::natMX4 
This study 
pbs2Δsch9Δ CLL134 BY4741; MAT a; his3Δ1; leu2Δ0; 
met15Δ0; ura3Δ0; pbs2::kanMX4 
sch9::natMX4 
This study 
hog1Δsch9Δ CLL137 MATα leu2 his3 trp1 ura3 
hog1::URA3 sch9::natMX4 
This study 
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2.1.1 Growth Media 
 
All media and agar was prepared in distilled water and autoclaved.  
 
The S. cerevisiae strains used were initially pre-cultured in YPD [2% glucose, 1% 
peptone, 1% yeast extract], with relevant selections added as relevant for each strain 
to maintain mutations on agar plates. 
 
The minimal media used was YNB [0.67% yeast nitrogen base without amino acids 
(ForMedium™, UK) 2% glucose and 0.002%, appropriate amino acids except for 
threonine, uracil, tyrosine, lysine at 0.001% and 0.005% leucine], amino acid deficient 
media were also prepared for use as selection media for some deletions or plasmids 
insertions. Cells were grown at 30oC at 180 rpm in 250ml conical flasks. 
 
For growth of DH5-α Escherichia coli (E. coli) Luria Broth (LB) [1% tryptone, 0.5% 
yeast extract, 1% NaCl] was utilised with growth conditions of 37oC with 200rpm 
shaking in 50ml falcon tubes. LB with 100μg/ml ampicillin was used to select for cells 
with successfully transformed plasmids or vectors. LB agar (2% agar and 100μ/ml 
ampicillin) was used to select for cells with successfully transformed plasmids or 
vectors after transformation.  
 
2.1.2 Growth curves 
 
Growth curves were conducted in YNB in duplicate, yeast was pre-cultured in YPD 
overnight before resuspending to a density of ~2.0 x 106 cells/ml (OD595nm ~ 0.1). 
dga1-3HA  CLL126 BY4741; MATa; his3Δ1; leu2Δ0; 
met15Δ0; ura3Δ0; dga1-3HA-natMX6 
This study 
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Growth rates of all yeast strains used were monitored hourly using a 
spectrophotometer at a wavelength of 595nm.  
 
2.2 Nile red lipid screening 
 
Method used was as Rostron et al 2015. 
 
Stationary phase cells were harvested by centrifugation at 2000rpm for 2 mins. The cell 
pellet that formed was washed twice in phosphate buffered saline (PBS) [8% NaCl, 
0.2% KCl, 1.44% Na2HPO4, 0.24% KH2PO4] (Fisher, UK), to remove the high 
background fluorescence of the medium, before being resuspended in PBS; the optical 
density (at 595nm) was recorded following resuspension of the pellet.  
 
To a black clear bottomed 96-well plate each well had 25μl of DMSO/PBS (1:1 v/v) 
added, followed by 250μl of the suspended cell pellets in triplicate (in the case of the 
control this was replaced with PBS) and finally 25μl of Nile red in acetone (with a final 
concentration of 5 μg/ml). Wavelengths of excitation 485 nm emission 535 nm, for 
determining the amount of neutral lipid, were utilised on a Tecan Genios Pro plate 
reader.  
 
The data was processed to account for the background fluorescence of the PBS and to 
account for any variations in optical density after washing and resuspension in PBS.  
To combine the triplicate data the processed well data (for each triplicate) was 
averaged. 
 
Where relevant, statistical analyses were performed by means of one way ANOVA with 
Tukey post hoc comparisons using GraphPad Prism 7.0 software. A significant result 
was determined to have a p value of <0.05. 
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2.3 Yeast genomic DNA extraction 
 
Genomic DNA extractions were carried out as described by Lõoke et al. 2011 and was 
done from both liquid media and directly from fresh plates. From liquid 200μl of 
exponential culture (OD595 ~ 0.4) was harvested and centrifuged at 2000rpm for 2 
minutes, from plates, single colonies were harvested, cells were resuspended in 100μl 
of lysis buffer [0.2M LiAc, 1% SDS solution] and incubated for 5 minutes at 70oC. 300μl 
100% ethanol was added and samples vortexed before centrifuging at 15 000 x g for 3 
minutes. The resultant pellet was then washed with 70% ethanol before resuspension 
in 100μl of TE buffer [10 mM Tris-HCL pH 8, 1 mM EDTA]. 
 
2.3.1 Polymerase chain reaction (PCR) 
 
Primers utilised in this study are listed in table 2.2 and were synthesised by integrated 
DNA technologies (IDT, UK). 
 
Table 2.2: Table of primers designed and utilised for PCR. 
Primer  Sequence Restriction 
sites 
Dga1+promoter 
FP XhoI 
5’ ATA TAT CTC GAG GAT GAG ATT GCC TTT 
ACT GCG 3’ 
XhoI 
Dga1 Rev SacI 5’ ATA TAT GAG CTC GCA GAA TTG AAG ATA 
GTT GGG TAA 3’ 
SacI 
Dga1 S2 5’ TAA AAA ATC CTT ATT TAT TCT AAC ATA 
TTT TGT GTT TTC CAA TGA ATT CAT TAT TAA 
TCG ATG AAT TCG AGC TCG 3' 
 
Dga1 S3 5’ TAC GAA AAT AGA GAA AAA TAT GGG GTA 
CCG GAT GCA GAA TTG AAG ATA GTT GGG 
TCG TAC GCT GCA GGT CGA C -3' 
 
Dga1 S17 F 5' GGA AGA AGG AAG GAG CCC CTA CAG 
CCG GTA TTA C 3' 
 
Dga1 S17 R 5' GTA ATA CCG GCT GTA GGG GCT CCT TCT 
TCC TTC C 3' 
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Dga1 T53 F 5' CAT GCT GTC CAT TGG CGG CCC CTT TTG 
AAA GAA G 3' 
 
Dga1 T53 R 5' CTT TCA AAA GGG GCC AAT GGA CAG CAT 
G 3' 
 
Sch9 For 
100bp UP 
5' CTC ACA TAA TCA CCT AAG GGC ATC 3'  
Sch9 Rev 
150bp Down  
5' GTG ATA AAC TAG AAA TTT GCA GGA ACA 
ATT ATT C 3' 
 
Sch9 For ORF 
+ Prom BamHI 
5' ACA CAC GGA TCC ATG ATG AAT TTT TTT 
ACA TC 3' 
BamHI 
Sch9 Rev ORF 
XbaI 
5' GTG TGT TCT AGA TCA TAT TTC GAA TCT 
TCC ACT-3 
XbaI 
Nat FOR 5' GAG GCC CAG AAT ACC CTC 3'  
Nat REV 5' GGG CAG ATG ATG TCG AGG 3'  
Dga1 Seq F 5' CCA AGC ACG ACA GTG GTC TAT C 3'  
Dga1 Seq2 5' CTA GAG TCA TGC TGT CCA TTG G 3'  
Dga1 T84 For 5' ATT TGC AAT CTC GGC ACC AGC ACT GTG 
GGT 3' 
 
Dga1 T84 Rev 5' ACC CAC AGT GCT GGT GCC GAG ATT 
GCA AAT 3' 
 
Dga1 S103 For 5' TTT TCG ATA GGG CTC CTG CAA CTG GC 
3' 
 
Dga1 S103 
Rev 
5' GCC AGT TGC AGG AGC CCT ATC GAA AA 
3' 
 
Sch9 S1 5'AAA AGA AAA GGA AAA GAA GAG GAA GGG 
CAA GAG GAG CGA TTG AGA AAT CAA TC 
 
Sch9 S2 5’ TCT GAG AAT TAT ACT CGT ATA AGC AAG 
AAA TAA AGA TAC GAA TAT ACA ATA TGC 
GTA CGC TGC AGG TCG AC 3' 
 
M13 For 5' GTA AAA CGA CGG CCA GT '3  
M13 Rev 5' AAC AGC TAT GAC CAT G '3  
 
2.3.1.1 Amplification of the SCH9 gene from S. cerevisiae gDNA by PCR 
 
Primers Sch9 For ORF + Prom BamHI and Sch9 Rev ORF Xbal were used to amplify 
SCH9 ORF, including 1000 bp upstream of start, from S. cerevisiae genomic DNA 
(gDNA). 
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A 1x reaction consisted of 1x Biomix Red, 0.2 µM primers and ~250ng template gDNA 
from wild type S. cerevisiae.    
 
PCR conditions were as follows; 
 
1. Initial denaturation    95oC, 5 minutes 
2. Denaturation   95oC, 30 seconds 
3. Annealing      45oC, 30 seconds    30 cycles 
4. Extension     72oC, 2 minutes 30 seconds 
5. Final Extension    72oC, 7 minutes 
 
2.3.1.2 Amplification of SCH9 Deletion and 3HA tagging cassettes 
 
Primers Sch9 S1 and Sch9 S2 were used to create and amplify an SCH9 deletion 
cassette, using NAT as a selector, a 1x reaction consisted of; 1x HF Buffer, 200 µM 
dNTPs, 1µM of each primer 50ng template DNA (pFA6aNatMX), 1 µM MgCl2 and 
0.02U/ µl Phusion polymerase.  
 
Primers Dga1 S2 and Dga1 S3 were used to create and amplify a 3’ 3HA tagged 
DGA1. A 1x reaction consisted of 1x HF Buffer, 200 µM dNTPs, 0.2 µM of each primer 
50ng template DNA (pFA6aNatMX), 1 µM MgCl2 and 0.02U/ µl Phusion polymerase.  
 
PCR conditions were as follows; 
 
1. Initial denaturation    98oC, 3 minutes 
2. Denaturation   98oC, 1 minute 
3. Annealing      58oC, 1 minute   35 cycles 
4. Extension     72oC, 1 minute  
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5. Final Extension    72oC, 7 minutes 
 
SCH9 deletion cassette products were pooled and ethanol precipitated before 
transformation into S. cerevisiae strains. 
 
Ten PCR reactions of the dga1-3HA tagging cassette were pooled prior to 
transformation into S. cerevisiae strains. 
 
2.3.1.3 Amplification of DGA1 from S. cerevisiae gDNA by PCR 
 
Primers Dga1+promoter FP XhoI and Dga1 Rev SacI were used to amplify DGA1 
ORF, including 1000bp upstream of the start, from S. cerevisiae gDNA. A 1x reaction 
(for 50µl) consisted of 1x HF Buffer, 200 µM dNTPs, 1µM of each primer 50ng template 
gDNA, 1 µM MgCl2 and 0.02U/µl Phusion polymerase. 
 
PCR conditions were as follows; 
1. Initial denaturation    98oC, 3 minutes 
2. Denaturation   98oC, 1 minute 
3. Annealing      59oC, 1 minute        35 cycles 
4. Extension     72oC, 2 minutes 30 seconds 
5. Final Extension    72oC, 7 minutes 
6. Hold at 21oC 
 
2.3.1.4 Mutagenesis of DGA1 
 
Primers were used to create and amplify Dga1 mutants of. Dga1mutations all result in 
a substitution of serine or threonine to alanine, at positions S17 (S17 For, S17 Rev), 
T53 (T53 For, T53 Rev), T84 (T84 For, T84 Rev) and S103 (S103 For, S103 Rev) 
using mutagenesis primers (see brackets for primers in relation to the mutation they 
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cause; E.g. substitution of serine to alanine at position 17 (S17) will utilise the S17 For 
and S17 Rev primers. 
 
Two different methods of PCR were attempted, first a QuikChange method was used 
(as detailed in the “QuikChange II Site-Directed Mutagenesis Kit” by Agilent 
Technologies), and extended primer (or “SOEing”) PCR; this was done due to the 
failure of the QuikChange method to generate a product that was able to transform 
properly into DH5α cells. 
 
QuikChange Method is a single method using TOPOdga1 (dga1 in a TOPO vector) as 
a template. The whole plasmid is copied using the PCR primers, resulting in a plasmid 
with the point mutation integrated into the DGA1 in the plasmid. A 1x reaction consisted 
of 1× reaction buffer, 50 ng of dsDNA template, 125 ng of Dga1 S17 F, 125 ng of Dga1 
S17 R, 200 µM dNTPs and 0.02U/µl Pfu polymerase. This was then digested with the 
restriction endonuclease DpnI as per the manufactures instructions (Thermo Scientific) 
to remove parental DNA 
 
PCR conditions were as follows; 
  
1. Initial denaturation    95oC, 30 seconds 
2. Denaturation   95oC, 30 seconds 
3. Annealing      55oC, 1 minute  
4. Extension     68oC, 14 minutes  
5. Hold at 21oC 
 
The Extended primer PCR method consisted of 3 reactions, the products of the first 
two being the template of the third. 
 
 12 cycles 
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Mutagenesis 1 and 2 PCRs were performed with a normal Dga1 primer and a 
mutagenesis primer that was in the inverse direction, (e.g. a Forward Dga1 primer and 
a reverse mutagenesis primer such as Dga1+promoter FP XhoI and S17 Rev) 
 
A 1x reaction consisted of 1x HF Buffer, 200µM dNTPs, 1µM of each primer 1ng 
template DNA (pTOPO-DGA1) and 0.02U/µl Phusion polymerase. 
 
PCR conditions were as follows; 
 
1. Initial denaturation    98oC, 30 seconds 
2. Denaturation   98oC, 30 seconds 
3. Annealing      59oC, 30 seconds    35 cycles 
4. Extension     72oC, 2 minutes 30 seconds 
5. Final Extension   72oC, 7 minutes 
6. Hold at 21oC 
 
The products were then gel extracted and then used in mutagenesis 3. 
 
A 1x reaction consisted of 1x HF Buffer, 200µM dNTPs, 1µM of each primer, 2ng 
template DNA (R1 + R2), 3% DMSO and 0.02U/ µl Phusion polymerase  
 
PCR conditions were as follows; 
  
1. Initial denaturation    98oC, 30 seconds 
2. Denaturation   98oC, 30 seconds 
3. Annealing      69oC, 30 seconds (-1oC every cycle)  
4. Extension     72oC, 1 minute 30 seconds 
5. Denaturation   98oC, 30 seconds 
 
 
 
10 cycles 
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6. Annealing      59oC, 30 seconds   
7. Extension     72oC, 1 minute 30 seconds 
8. Final Extension   72oC, 7 minutes 
9. Hold at 21oC 
 
2.4.1 Cloning PCR products into vectors 
Table 2.3: Table of plasmids utilised in this study 
Plasmid 
name  
Base 
vector  
Selectable 
markers/promoter  
Construction  Source  
pRS313 pRS313 Amp/HIS3 N/A Lab stock 
pRS316 pRS316 Amp/URA3 N/A Lab stock 
pFA6a-
natMX6 
pFA6a-
natMX6 
Amp/NatMX N/A Lab stock 
pRS313SCH9 pRS313 Amp/HIS3 SCH9 upstream of 
ATG cloned into 
BamHI and XbaI 
sites of pRS313 
This Study 
pRS316DGA1 pRS316 Amp/URA3 DGA1 upstream of 
ATG cloned into 
XbaI and SacI sites 
of pRS316 
This Study 
pRS313HOG1 pRS313 Amp/HIS3 HOG1 upstream of 
ATG cloned into 
BamHI and XbaI 
sites of pRS313 
Lab stock 
 30 cycles 
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TOPO TOPO Amp/Kan N/A Invitrogen 
 
 
2.4.1.1 Cloning PCR products into a TOPO vector 
 
Taq polymerase PCR products, were cloned into TOPO as per manufacturer’s 
instructions (Invitrogen). These were left overnight and were transformed into DH5α E. 
coli. 
 
For PCR products from proofreading enzymes a poly-A tail had to first be added before 
they could be cloned into TOPO. Reactions consisted of 1 x Taq buffer, 66 µM dATP, 
~20ng DNA and 0.025U/μl Taq polymerase. Samples were incubated at 70oC for 
15minutes before being using directly in TOPO ligation.  
 
2.4.1.2 Cloning PCR products into pRS vectors 
 
First both PCR products and the vector were digested with relevant fast digest 
restriction enzymes (as per the restriction enzyme sites on the primers used in the 
PCR; these were chosen to not cut the amplified gene at any position, the restriction 
sites alone would be cut and allow for insertion into the vector) [Thermo Scientific]. 
Digests were performed as per manufacturer’s instructions but were left for 1 hour at 
37oc. These were then cleaned with a NucleoSpin® Gel and PCR Clean-up kit 
(Macherey-Nagel) to remove the enzyme and any unreacted reactants from PCR left 
over, they were both eluted into the minimum volume allowed for by the kit.  
 
These were then ligated with T4 Ligase (Thermo Scientific) as per manufacturer’s 
instructions for sticky-end ligation but were left overnight at RT; the manufacturer 
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recommended a 1 hour ligation, instead ligations where performed over night to ensure 
the best chance of successful ligation (a 1 hour ligation proved to be unreliable). 
 
5μl of the ligation was added to 50μl of chemically competent DH5α E. coli cells and 
incubated on ice for 1 hour. This was heat shocked at 42oC for 2 minutes and left on 
ice for 2 minutes. 1ml of LB was added and the cells left to recover for 1 hour at 37oC 
with shaking at 200rpm. This was centrifuged at 11,000 g for 30 seconds, 800μl of LB 
is removed, the pellet is resuspended in the remaining 200μl and spread onto an LB 
plate with 100μg/ml ampicillin and grown overnight at 37oC. Colonies were 
resuspended in 10μl of sterile distilled water, a colony PCR was performed using M13 
forward and reverse primers. Reactions consisted of 1 x BioMix™ red, 1µM of each 
primer and 5µl of resuspended E. coli cells per 25µl reaction.  
 
PCR conditions were as follows; 
 
1. Initial denaturation    95oC, 5 minutes 
2. Denaturation   95oC, 30 seconds 
3. Annealing      45oC, 30 seconds    30 cycles 
4. Extension     72oC, 2 minutes 30 seconds 
5. Final Extension    72oC, 7 minutes 
 
Those colonies that gave successful amplification of a product of the correct size were 
resuspended in 10ml of LB ampicillin and allowed to grow overnight 37oC to  allow for 
plasmid preparation the following day.  
 
2.4.1.3 Transformation of cassettes into S. cerevisiae 
 
Preparation and transformation of S. cerevisiae competent cells was carried out as 
detailed in Janke et al. 2004. Mid exponentially growing cells (7 hours) were harvested 
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by centrifugation at 492 x g for 5 minutes and washed once with 0.5 volumes of sterile 
water and once with 0.2 volumes of SORB [100mM LiAc, 10mM Tris-HCl pH 8, 1mM 
EDTA/NaOH pH 8, 1M sorbitol; adjusted to pH 8 with dilute acetic acid]. 
 
SORB was removed by aspiration and cells resuspended in 360μl SORB per 50ml 
culture and 1mg/ml salmon sperm carrier DNA added (Invitrogen, UK). The cells were 
stored at 80oC until needed for transformation. They were defrosted prior to use. 
 
50μl of prepared competent cells were added to 4μg plasmid DNA and mixed well 
before addition of a six-fold volume of PEG [100mM LiAc, 10mM Tris-HCl pH 8, 1mM 
EDTA/NaOH pH 8, 40% PEG 4000 (Fisher, UK)]. The suspension was incubated for 30 
minutes at room temperature, mixing throughout. 10% DMSO was added before heat 
shocking the cells at 42oC for 15 minutes. Cells were pelleted by centrifugation for 2 
minutes at 300 x g, the supernatant removed and cells resuspended in 1000μl of YPD 
liquid medium and left to grow overnight at 30oc at 180 rpm before plating onto 
selective medium. 
 
2.5 SDS-PAGE and western blotting 
 
2.5.1 Denatured protein extraction 
 
Denatured protein extractions were carried out as described by Lawrence et al 2007. 
 
Cells were harvested at 492 x g from samples frozen in liquid nitrogen (LN) before 
resuspension in 1ml of 0.3M NaOH followed by the addition of 150μl of 55% (w/v) 
trichloroacetic acid. Samples were centrifuged at 4oC at 19000g for 1 minutes before 
aspiration of supernatant. The pellet was then resuspended in 30μl SDS sample buffer 
[50 mm Tris-Cl (pH 6.8), 2% SDS (w/v), 0.1% bromophenol blue, 10% (v/v) glycerol] 
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per Abs595nm 0.1 of cells. Proteins were denatured at 95oC for 10 minutes and allowed 
to cool before having 1μl of Dithiothreitol (DTT) added per 100μl of overall volume.  
 
2.5.2 Gels of protein extractions 
 
12% polyacrylamide gels were prepared [for running portion; 12% acrylamide, 0.39M 
Tris (pH 8.8), 0.1% Sodium dodecyl sulphate (SDS), 0.1 % 
Tetramethylethylenediamine (TEMED), and 0.1% Ammonium persulphate (APS). For 
stacking portion; 5.1% acrylamide, 0.13M Tris (pH 6.8), 0.1% SDS, 0.1% TEMED, and 
0.1% APS], protein extraction samples were then loaded into the wells. Gels were run 
in pairs at 300 volts at 20 mA per gel in a running buffer [0.033M Tris base, 0.3M 
glycine, and 0.0035M SDS].  
 
2.5.3 Western blotting 
 
Proteins were transferred from the 12% polyacrylamide gel to nitrocellulose membrane 
by application of a constant voltage (90 volts) for 1 hour in transfer buffer [25 mM Tris-
HCl (pH 7.6), 192 mM glycine, 20% methanol). This was then blocked with 10% milk in 
Tris buffered saline tween (TBST) [50 mM Tris HCl, pH 7.4, 150 mM NaCl, 0.1% 
Tween 20] for one hour before applying the primary antibody and leaving overnight at 
4oC. Three washes of 15 minutes in TBST were done to remove the excess primary 
antibody. Secondary antibody was added and incubated at room temperature for 45 
minutes, before another three washes of 15 minutes TBST to remove excess 
secondary antibody. 
 
Antibodies utilised by the present study were: α-Hog1p to detect total amounts of 
Hog1p (Santa Cruz Biotechnology), 1:1000 dilution in TBST. α-P-p38 to detect dually 
phosphorylated Hog1p (Cell Signalling Technology), 1:1000 dilution in TBST. Rabbit 
IgG, HRP-linked secondary antibody (from donkey) was used at a dilution of 1:10000 in 
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TBST for α-Hog1p and α-P-p38. HA primary antibody was used in a 1:1000 dilution in 
TBST with mouse IgG, HRP-linked secondary antibody (from donkey) was used at a 
dilution of 1:10000 in TBST.  
 
Westerns were visualised using ECL prime solutions (GE Healthcare) as per 
manufacturer’s instructions.  
 
2.5.4 Phos-tagTM  
Phos-Tag TM gels were run to try to separate proteins by their phosphorylation status 
(e.g. how many times a protein is phosphorylated). Phos-Tag TM gels were prepared as 
per 2.5.2 but with the addition of a final concentration of 0.05mM Phos-tag tagTM AAL 
Solution and 0.1 mM MnCl2 solution (a 0.2 mM MnCl2 solution was used when a 0.1 
mM MnCl2 solution failed to transfer properly). These were run as 2.5.2 but for a 
minimum of 2 hours. Western blotting was as per 2.5.3 but prior to transfer Phos-tagTM 
gels were washed in transfer buffer with 1 mM EDTA for 10 minutes and in normal 
transfer buffer for 10 minutes.  Transfer was done for 2.5 hours at 90 volts.  
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3.0 Results 
 
3.1. The MAPK Hog1 is required for neutral lipid accumulation   
 
Lipogenesis is a metabolic process whereby lipids are formed from fatty acids, these 
fatty acids are themselves formed though a series of biosynthetic reactions starting 
which use acetyl-CoA as their starting point. Cancer cells undergo many changes to 
their cellular metabolism, so the process of lipogenesis becomes dysregulated. This 
results in cancer cells have altered lipid metabolism (Walther  and Farese2012) which, 
due to the Warburg effect (Diaz-Ruiz et al, 2011; Liberti et al, 2016), results in cells 
accumulating more lipid (Baenke et al, 2013). This altered metabolism provides the 
cancer cells with both energy and increased lipid synthesis required to support their 
proliferation (Liberti et al, 2016). This altered lipid metabolism makes cancer cells 
distinct from healthy body cells, an altered phenotype may allow for treatments which 
select for that phenotype, in effect for cancer.  
 
In mammalian cells, mTOR has a well-established role in regulating lipid metabolism 
(Laplante et al, 2009a, Laplante et al 2012b) but there is also some evidence that the 
MAPK, p38, might also have a role in lipid metabolism regulation, with p38 implicated 
in cancer cell proliferation, angiogenesis and metastasis (Leelahavanichkul et al 2014, 
Mao et al 2010). 
 
S. cerevisiae is a well-established model organism (Henr et al, 2012; Zhang et al, 
2003) and has been previously used to characterise lipid metabolism in mammalian 
cells (Schmidt et al, 2013; Koch et al, 2014; Diaz-Ruizet al, 2011). S. cerevisiae is easy 
to work with, cells accumulate neutral lipid when nitrogen in the media has been 
expended and cells enter stationary phase (Kolouchova et al, 2016, Natteret al, 2013). 
Once in stationary phase neutral lipid levels can be assessed using the Nile Red 
method (Rostron et al, 2015). 
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It also has highly conserved MAPK pathways, Hog1p is the S. cerevisiae orthologue of 
the mammalian MAPK p38 (Banuett 1998), acting primarily as the cellular response to 
osmotic stress. Previous unpublished work suggests a link between the MAPK Hog1 
and neutral lipid accumulation. S. cerevisiae.  
 
To determine the role of the MAPK pathway in neutral lipid accumulation in yeast, a 
series of HOG MAPK S. cerevisiae genomic deletion mutants were investigated; 
ssk2Δ, ste11Δ, pbs2Δ, hog1Δ (Figure 1.7). Initially, growth curves were undertaken to 
investigate whether the deletions affected overall cell growth and to determine the time 
point for entry into stationary phase. Growth curves (Figures 3.1 – 3.6) indicate that the 
HOG pathway mutants have similar growth rates when compared to the wild type S. 
cerevisiae. Further, all strains enter stationary phase at a similar time indicating that 
18hrs was an appropriate time point to measure neutral lipid levels as used in Rostron 
et al, 2015. Levels of neutral lipid in stationary phase for each mutant was then 
determined using a Nile Red assay, previously described by Rostron et al, 2015.  Two 
additional mutants, lro1Δ and fat1Δ, were used as negative and positive controls, 
respectively; lro1Δ and fat1Δ would accumulate less and more lipid respectively 
(Rostron et al, 2015) and so were used as controls to ensure that the assay was 
properly functioning. 
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Figure 3.1. Growth curve of S. cerevisiae wild type and ssk2Δ under normal 
conditions in yeast nitrogen base medium (YNB). Cultures were diluted to 2 x 106 
cells (OD595 ~0.1) and incubated with shaking, 180rpm, at 30oC. Optical density 
readings at 595nm were taken hourly until mid to late stationary phase was reached. 
 
 
 
Figure 3.2. Growth curve of S. cerevisiae wild type and ste11Δ under normal 
conditions in yeast nitrogen base medium (YNB). Cultures were diluted to 2 x 106 
cells (OD595 ~0.1) and incubated with shaking, 180rpm, at 30oC. Optical density 
readings at 595nm were taken hourly until mid to late stationary phase was reached. 
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Figure 3.3. Growth curve of S. cerevisiae wild type and pbs2Δ under normal 
conditions in yeast nitrogen base medium (YNB). Cultures were diluted to 2 x 106 
cells (OD595 ~0.1) and incubated with shaking, 180rpm, at 30oC. Optical density 
readings at 595nm were taken hourly until mid to late stationary phase was reached. 
 
 
Figure 3.4. Growth curve of S. cerevisiae wild type and hog1Δ under normal 
conditions in yeast nitrogen base medium (YNB). Cultures were diluted to 2 x 106 
cells (OD595 ~0.1) and incubated with shaking, 180rpm, at 30oC. Optical density 
readings at 595nm were taken hourly until mid to late stationary phase was reached. 
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Figure 3.5. Growth curve of S. cerevisiae wild type and lro1Δ under normal 
conditions in yeast nitrogen base medium (YNB). Cultures were diluted to 2 x 106 
cells (OD595 ~0.1) and incubated with shaking, 180rpm, at 30oC. Optical density 
readings at 595nm were taken hourly until mid to late stationary phase was reached. 
 
 
Figure 3.6. Growth curve of S. cerevisiae wild type and fat1Δ under normal 
conditions in yeast nitrogen base medium (YNB). Cultures were diluted to 2 x 106 
cells (OD595 ~0.1) and incubated with shaking, 180rpm, at 30oC. Optical density 
readings at 595nm were taken hourly until mid to late stationary phase was reached. 
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Figure 3.7. Neutral lipid fluorescence intensity of Nile Red stained S. cerevisiae 
wild type and the HOG component mutants ssk2Δ, ste11Δ, pbs2Δ, hog1Δ, lro1Δ 
and fat1Δ. Cells were harvested 18 hrs post resuspension in YNB. Cells were washed 
twice in PBS before adjusting to a cell density of 2 x 107 cells/ml. 5 x 106 cells were 
transferred to the wells of black 96-well plates in triplicate. 25μl PBS/DMSO (1:1 v/v) 
and 5μg/ml Nile red were added to each sample. Plates were screened using the 
wavelengths: excitation 485nm, emission 535nm. Data shown as means of duplicates 
±SD. Significance indicated between wild type and hog1Δ and lro1Δ and fat1Δ. * 
p≤0.01 *** p≤0.001. Data analysed by one way ANOVA with Tukey post hoc test. 
 
Nile Red results (Figure 3.7) show no significant difference in neutral lipid accumulation 
in ssk2Δ, ste11Δ and pbs2Δ when compared to the wildtype. However, a significant 
decrease of 1.6-fold was observed in the hog1Δ strain when compared to the wildtype. 
The controls lro1Δ and fat1Δ accumulated 1.6-fold less and 1.13-fold more neutral lipid 
respectively as previously described (Rostron et al, 2015).  
 
To confirm that the loss of HOG1 was causing the reduction in neutral lipid 
accumulation, HOG1 was cloned into pRS316 and introduced into the hog1Δ strain. 
Neutral lipid levels were then measured and compared to the control, wild type and 
hog1Δ strain containing the vector pRS316 alone. 
***     *** 
* 
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Figure 3.8 shows a restoration of neutral lipid accumulation phenotype once HOG1 is 
reintroduced into cells on a plasmid, with hog1ΔpRS313HOG1 accumulating neutral 
lipid at a similar level to the wild type. 
 
Figure 3.8. Neutral lipid fluorescence intensity of Nile Red stained S. cerevisiae 
wild type and hog1Δ mutant with pRS313 and pRS313HOG1 transformed into 
both. Cells were harvested 18 hrs post resuspension in YNB. Cells were washed twice 
in PBS before adjusting to a cell density of 2 x 107 cells/ml. 5 x 106 cells were 
transferred to the wells of black 96-well plates in triplicate. 25μl PBS/DMSO (1:1 v/v) 
and 5μg/ml Nile red were added to each sample. Plates were screened using the 
wavelengths: excitation 485nm, emission 535nm. Data shown as means of duplicates 
±SD. Significance indicated between wild type and the hog1Δ and hog1ΔpRS313 
mutants. **** p≤0.0001. Data analysed by one way ANOVA with Tukey post hoc test. 
 
***       *** 
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These data suggest that Hog1p is involved in neutral lipid accumulation. This cause to 
further investigate Hog1p, its activation may be a good place to start. 
 
3.2 Hog1p phosphorylation is seen as cells began to accumulate neutral lipid 
Hog1p is activated via a dual phosphorylation on Thr174 and Ty176 (Maayan et al. 
2012), therefore, if Hog1p is important for neutral lipid accumulation activation of the 
protein should be observed as cells leave exponential growth and begin to enter 
stationary phase at approximately 10hrs.  
 
Cells were resuspended in YNB media and growth monitored over time via optical 
density at 595nm. Cells were harvested at 30 min intervals as cells progressed through 
exponential phase, between 6 and 10 hours of growth. The resulting protein extracts 
were analysed via a western blot using a p38 antibody which detects dual 
phosphorylation of Hog1p at Thr174 and Ty176. Samples were also probed with a 
hog1 antibody to determine total Hog1p levels.  
 
Figure 3.9. Duplicate Western blot of protein extractions from wild type S. 
cerevisiae cells over a time course of 6 to 10 hours of growth in YNB media and 
incubated with shaking, 180rpm, at 30oC. Membranes were first probed with a p38 
antibody before being stripped and reprobed with a Hog1 antibody.  
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Westerns (Figure 3.9) show dual phosphorylation of Hog1p from 6 to 7.5 hours, 
followed by its loss at 8 and 8.5 hours, before dual phosphorylation is seen again from 
9hrs onwards.  
 
In the early exponential phase samples (6 – 7.5 hours) Hog1p is dually phosphorylated 
at Thr174 and Ty176 due to the transition from lag phase to exponential phase. In the 
mid exponential phase (8 – 8.5 hours), where the cells have adapted to the 
environment, there is no detectable phosphorylation at Thr174 and Ty176, indicating a 
lack of activation of Hog1p. In later exponential (9 – 10 hours) there is again 
phosphorylation at Thr174 and Ty176 indicating a reactivation of Hog1p. This data 
suggests an activation of Hog1p, possibly via phosphorylation, as cells approach 
stationary phase where they begin to accumulate neutral lipid.  
 
3.3 Hog1p activation appears to be Pbs2p independent  
 
Data has shown that neutral lipid accumulation is reduced in the absence of Hog1p 
(hog1Δ cells) (Figure 3.7) and that Hog1p is phosphorylated at Thr174 and Ty176 as 
cells enter stationary phase (Figure 3.8. Hog1p is a well-established target of the 
MAPKK Pbs2p (Maayan et al. 2012), however pbs2Δ mutants show wild type levels of 
neutral lipid (Figure 3.7). 
 
To investigate the role of Pbs2p and its regulation of Hog1p in neutral lipid 
accumulation, a hog1Δpbs2Δ double deletion strain was made. A growth curve of the 
hog1Δpbs2Δ mutant strain was undertaken and determined that it had similar growth 
phenotype to wildtype cells (Figure 3.10). To determine its effect on neutral lipid 
accumulation, Nile red assay was then performed with wild type, pbs2Δ, hog1Δ and 
hog1pbs2Δ cells, to determine neutral lipid levels in stationary phase. 
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Figure 3.10. Growth curve of S. cerevisiae wild type and hog1Δpbs2Δ under 
normal conditions in yeast nitrogen base medium (YNB). Cultures were diluted to 2 
x 106 cells (OD595 ~0.1) and incubated with shaking, 180rpm, at 30oC. Optical density 
readings at 595nm were taken hourly until mid to late stationary phase was reached. 
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Figure 3.11. Neutral lipid fluorescence intensity of Nile Red stained S. cerevisiae 
wild type and pbs2Δ, hog1Δ and hog1Δpbs2Δ mutants. Cells were harvested 18 
hrs post resuspension in YNB. Cells were washed twice in PBS before adjusting to a 
cell density of 2 x 107 cells/ml. 5 x 106 cells were transferred to the wells of black 96-
well plates in triplicate. 25μl PBS/DMSO (1:1 v/v) and 5μg/ml Nile red were added to 
each sample. Plates were screened using the wavelengths: excitation 485nm, emission 
535nm. Data shown as means of duplicates ±SD. Significance indicated between wild 
type and the hog1Δ single and double delete mutants. ** p≤0.01. Data analysed by one 
way ANOVA with Tukey post hoc test. 
 
Nile red data (Figure 3.11) showed similar levels of neutral lipid accumulation in both 
the wild type and pbs2Δ strain but a significant reduction in hog1Δ and hog1Δpbs2Δ, 
with levels being approximately half that of the wild type. 
 
Data shows that there is no reduction in neutral lipid levels in a pbs2Δ single deletion 
and there was no additive effect for the hog1Δpbs2Δ double deletion mutant, 
suggesting that Pbs2p isn’t required for cells to accumulate neutral lipids.  
 
**     ** 
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As data suggests that Hog1p activation is required for neutral lipid accumulation but 
Pbs2p is not, this indicates that Hog1p may be activated in a Pbs2p independent 
manner. As such, the phosphorylation state of Hog1p in late exponential phase was 
investigated in the presence and absence of Pbs2p. 
 
Cells from wild type and pbs2Δ S. cerevisiae were grown in YNB and harvested at 8 to 
10 hours of growth (the period that in Figure 3.8 showed a change in Hog1p 
phosphorylation at Thr174 and Ty176) and frozen in liquid nitrogen. Proteins were 
extracted, run on acrylamide gels and western blots performed. 
 
 
Figure 3.12. Duplicate Western blot of protein extractions from wild type and 
pbs2Δ S. cerevisiae cells over a time course of 8 to 10 hours of growth in YNB 
media and incubated with shaking, 180rpm, at 30oC. Membranes were first probed 
with α-p38 antibody before being stripped and reprobed with Hog1p antibody. 
 
Western blot data (Figure 3.12) shows a lack of dual phosphorylation at Thr174 and 
Ty176 across all time points investigated in the pbs2Δ cells, this differs from the wild 
type where dual phosphorylation is seen at 9 and 9.5 hours of growth; there is no dual 
phosphorylation at 8 or 8.5 hours as previously observed (Figure 3.11). The negative 
control of hog1Δ displayed no Hog1p in the cells as expected. 
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This data suggests that the dual phosphorylation at Thr174 and Ty176 observed during 
late exponential phase is as a result of Pbs2p. Dual phosphorylation doesn’t appear to 
be essential for lipid accumulation as pbs2Δ lack dual phosphorylation at Thr174 and 
Ty176 neutral lipid accumulation still occurs (Figure 3.7). 
 
As in pbs2Δ cells, Hog1 is not dually phosphorylated at Thr174 and Ty176 (Figure 
3.12), it is possible that Hog1p is being phosphorylated and activated at alternative 
sites and/or only phosphorylated at one of these sites. 
 
To determine whether Hog1p is being phosphorylated independently of Pbs2p as cells 
undergo the lipogeneic switch, a Phos-tagTM was used to examine the phosphorylation 
state of Hog1p in a pbs2 strain. A Phos-tagTM gel was used to its ability to separate 
the proteins by their phosphorylation status, proteins with more sites phosphorylated 
will stay higher in the gel than those with less phosphorylation. As data shows a lack of 
phosphorylation at Thr174 and Ty176 in pbs2Δ cells we wanted to determine the 
number of phosphorylations (if any) on Hog1p in the pbs2Δ cells and compare them 
with the wild type. This would confirm whether Hog1p phosphorylation is needed for 
neutral lipid accumulation. To optimise the protein shift observed various 
concentrations of MnCl2 (0.1mM to 0.2mM) were added to the protein gel. In addition, 
for the western blot analysis, due to reduced transfer efficiency the time was increased 
from 1 hour to 2.5 hours.     
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Figure 3.13.1 Western blot of Phos-tagTM gel (Gel A), Gel A did not transfer properly, 
and of a normal acrylamide gel (Gel B) of protein extractions from wild type and pbs2Δ 
S. cerevisiae cells over a time course of 8 to 10 hours of growth in YNB media and 
incubated with shaking, 180rpm, at 30oC. Phos-tagTM gel was run with 0.1mM MnCl2 
and transferred for 1 hour. Membranes were probed with hog1 antibody, an ECL 
secondary antibody was added to each primary to allow for visualisation on a Biorad™ 
ChemiDoc™ XRS+ machine. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A 
B 
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Figure 3.13.2. Western blot of Phos-tagTM gel (Gel A) and of a normal acrylamide gel 
(Gel B) of protein extractions from wild type and pbs2Δ S. cerevisiae cells over a time 
course of 8 to 10 hours of growth in YNB media and incubated with shaking, 180rpm, 
at 30oC. Phos-tagTM gel was run with 0.2mM MnCl2 and transferred for 2.5 hours. 
Membranes were probed with p38 antibody first, then stripped and reprobed with hog1 
antibody, an ECL secondary antibody was added to each primary to allow for 
visualisation on a Biorad™ ChemiDoc™ XRS+ machine. 
 
Wild type and pbs2Δ protein samples were initially run on a normal gel to confirm 
Hog1p and its dual phosphorylation state could be visualised and to ensure equal 
loading of the wells. Phospho-38 was not detected on the Phos-tagTM gel (Figure 
3.13.2 A) but was detected on the regular gels (Figure 3.13.2 B). Gel A (Figure 3.13 A) 
did not transfer properly. On the Phos-tagTM gels (Figures 3.13.1 A and Figure 3.13.2 
A) no shift is seen, this combined with the fact that the wild type 8 and 8.5 hours, which 
A 
B 
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show no dual phosphorylation at Thr174 and Ty176 (Figure 3.12), have the same 
position in the gel as the 9, 9.5 and 10 hours, which are dually phosphorylated at 
Thr174 and Ty176 (Figure 3.9), suggests that the Phos-tagTM gel has not worked 
properly. 
 
3.4 Sch9p is required for neutral lipid accumulation 
As Pbs2p appears not to be involved in Hog1p activation in neutral lipid accumulation, 
therefore phosphorylation be Pbs2p is not required for the activation of Hog1p in 
neutral lipid accumulation. A different kinase may be phosphorylating Hog1p at 
different sites, a potential candidate is Sch9p (a target of the Tor 1 complex) with 
evidence that it is potentially involved in the phosphorylation of Hog1p under conditions 
of osmotic stress (Pascual-Ahuir and Proft 2007).  
 
sch9Δ cells were made via homologous recombination using an SCH9 NAT deletion 
cassette. The SCH9 deletion cassette was successfully amplified (Figure 3.14 A). 
Successful integration of the cassette into wild type S. cerevisiae was confirmed by 
PCR (Figure 3.14 B). Growth curves of the sch9Δ deletion strain (Figure 3.15 –3.16) 
showed no significant growth difference from the wild type. As no growth defects were 
observed, Nile Red assays were performed to determine levels of neutral lipids in the 
sch9Δ.  
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A. 
 
 
 
 
B. 
 
 
 
 
C.  
 
 
 
 
 
Figure 3.14. (A) Amplification of SCH9 deletion cassettes. 1% agarose gel 
displaying amplification of a sch9 deletion cassette utilising Sch9 S1 and S2 primers 
with a pFA6aNatMX6 template. Product was ~1.5kb in lane 1, lane 2 was a negative 
control. 
(B) Testing of integration of cassette into wild type S. cerevisiae. 1% agarose 
displaying amplification from wild type S. cerevisiae gDNA with SCH9 deletion cassette 
transformed in using Sch9 Up 100bp and Nat Rev primers using Taq polymerase. 
Products were of the expected size of ~1.3kb in lanes 1 and 4, these had successfully 
integrated the cassette, lanes 2 and 3 had not successfully integrated the cassette so 
no product was produced.  
(C) Testing of integration of cassette into hog1Δ and pbs2Δ S. cerevisiae. 1% 
agarose displaying amplification from hog1Δ and pbs2Δ S. cerevisiae gDNA with SCH9 
deletion cassette transformed in using Sch9 Up 100bp and Nat Rev primers using Taq 
polymerase. Products were of the expected size of ~1.3kb in lanes 1 – 7 were hog1Δ, 
lanes 8-11 were pbs2Δ. 
 
L1        L2 
L1                L2            L3             L4 
L1       L2       L3       L4      L5       L6      L7  
L8           L9       L10       L11 
1500bp 
 
1000bp 
1500bp 
1500bp 
 
1000bp 
1500bp 
 
1000bp 
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Figure 3.15. Growth curve of S. cerevisiae wild type and sch9Δ under normal 
conditions in yeast nitrogen base medium (YNB). Cultures were diluted to 2 x 106 
cells (OD595 ~0.1) and incubated with shaking, 180rpm, at 30oC. Optical density 
readings at 595nm were taken hourly until mid to late stationary phase was reached. 
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Figure 3.16.  Neutral lipid fluorescence intensity of Nile Red stained S. cerevisiae 
wild type and msn2/4Δ, sch9Δ, lro1Δ and fat1Δ mutants. Cells were harvested 18 
hrs post resuspension in YNB. Cells were washed twice in PBS before adjusting to a 
cell density of 2 x 107 cells/ml. 5 x 106 cells were transferred to the wells of black 96-
well plates in triplicate. 25μl PBS/DMSO (1:1 v/v) and 5μg/ml Nile red were added to 
each sample. Plates were screened using the wavelengths: excitation 485nm, emission 
535nm. Data shown as means of duplicates ±SD. Significance indicated between wild 
type and msn2/4Δ, lro1Δ and sch9Δ. * p≤0.1 **** p≤0.001. Data analysed by one way 
ANOVA with Tukey post hoc test. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
* 
****        **** 
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A. 
 
 
B. 
 
 
 
C. Nile Red of complementation  
 
Figure 3.17. Complementation of sch9 phenotype (A) 1% agarose gel displaying 
amplification of sch9 from gDNA with Sch9 ORF Forward and Reverse primers with 
banding occurring at 2.5kb in 3 cell samples (L1 – L3) 
2500bp 
2500bp 
     L1   L2   L3 
****        **** 
        L1    L2        L3 
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(B) 1% agarose gel displaying PCR results of miniprepped pRS313 plasmid with SCH9 
ORF Forward and Reverse primers showing successful integration of sch9 into the 
plasmid. Product size expected was ~ 2.5kb in 3 cell samples (L1 - L3) 
(C) Neutral lipid fluorescence intensity of Nile Red stained S. cerevisiae wild type and 
sch9Δ transformed with the plasmid pRS313 and pRS313SCH9. Cells were harvested 
18 hrs post resuspension in YNB. Cells were washed twice in PBS before adjusting to 
a cell density of 2 x 107 cells/ml. 5 x 106 cells were transferred to the wells of black 96-
well plates in triplicate. 25μl PBS/DMSO (1:1 v/v) and 5μg/ml Nile red were added to 
each sample. Plates were screened using the wavelengths: excitation 485nm, emission 
535nm. Data shown as means of duplicates ±SD. Significance indicated between wild 
type and sch9Δ and sch9ΔpRS313.  **** p≤0.0001. Data analysed by one way ANOVA 
with Tukey post hoc test. 
 
Nile Red results (Figure 3.16) show a significant decrease of 1.5-fold in neutral lipid 
accumulation in sch9Δ. The controls lro1Δ and fat1Δ behaved as previously described. 
 
To confirm that deletion of SCH9 was causing the observed neutral lipid phenotype, the 
strain was complemented with a wild type copy of SCH9 expressed from a plasmid. 
SCH9 was successfully amplified by PCR using wild type S. cerevisiae genomic DNA 
(Figure 3.17 A). The amplified SCH9 was  successfully cloned into the yeast vector 
pRS313 (Figure 3.17 B) and transformed into sch9Δ deletion cells. Nile Red data 
(Figure 3.17 C) showed no significant change in neutral lipid accumulation in between 
control wild type cells transformed with pRS313 and wild type cells containing 
pRS313SCH9. In sch9Δ cells containing the control vector, pRS313, a significant 
decrease in neutral lipid accumulation of 1.8-fold was observed. However, when sch9Δ 
cells contained pRS313SCH9, neutral lipid levels returned to those seen in the wild 
type. This data confirms that the neutral lipid phenotype observed in the sch9Δ strain is 
the result of loss of SCH9. 
 
This data suggests that SCH9 is required for neutral lipid accumulation as a deletion of 
this gene caused a significant decrease in neutral lipid accumulation, and its 
reintroduction caused a restoration of neutral lipid accumulation. 
 
 
 
67 
 
3.5 Hog1p is a potential target of the protein kinase, Sch9p 
 
Both Sch9p and Hog1p are required for neutral lipid accumulation, therefore it is 
possible that Sch9p and of Hog1p are involved in the same pathway. To determine this 
a double, delete mutant was created using a SCH9 NAT deletion cassette, resulting in 
hog1Δsch9Δ strain. In addition, to further investigate the upstream components of the 
HOG MAPK pathway, a pbs2Δsch9Δ strain was also produced. Both mutants were 
tested via PCR to ensure integration of the cassette (Figure 3.14 C). Growth curves 
(Figure 3.18 and Figure 3.19) showed no significant differences in growth between the 
double delete mutants and the wild type. A Nile Red assay was then performed to 
determine the neutral lipid phenotype of these mutants relative to the wild type. 
 
Figure 3.18. Growth curve of S. cerevisiae wild type and hog1Δsch9Δ under 
normal conditions in yeast nitrogen base medium (YNB). Cultures were diluted to 2 
x 106 cells (OD595 ~0.1) and incubated with shaking, 180rpm, at 30oC. Optical density 
readings at 595nm were taken hourly until mid to late stationary phase was reached. 
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Figure 3.19. Growth curve of S. cerevisiae wild type and pbs2Δsch9Δ under 
normal conditions in yeast nitrogen base medium (YNB). Cultures were diluted to 2 
x 106 cells (OD595 ~0.1) and incubated with shaking, 180rpm, at 30oC. Optical density 
readings at 595nm were taken hourly until mid to late stationary phase was reached. 
 
Figure 3.20.  Neutral lipid fluorescence intensity of Nile Red stained S. cerevisiae 
wild type and sch9Δ, hog1Δ and pbs2Δ single and double delete mutants. Cells 
**** 
**** **** 
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were harvested 18 hrs post resuspension in YNB. Cells were washed twice in PBS 
before adjusting to a cell density of 2 x 107 cells/ml. 5 x 106 cells were transferred to the 
wells of black 96-well plates in triplicate. 25μl PBS/DMSO (1:1 v/v) and 5μg/ml Nile red 
were added to each sample. Plates were screened using the wavelengths: excitation 
485nm, emission 535nm. Data shown as means of duplicates ±SD. Significance 
indicated between wild type and hog1Δ, hog1Δsch9Δ and sch9Δ. **** p≤0.0001. Data 
analysed by one way ANOVA with Tukey post hoc test. 
 
Nile Red data (Figure 3.20) shows a significant decrease in sch9Δ (1.8 fold) and hog1Δ 
(1.4 fold) (shown previously; Figure 3.7 and Figure 3.17) and in hog1Δsch9Δ (1.5fold). 
However, the pbs2Δsch9Δ strain showed that SCH9Δ neutral lipid phenotype is 
rescued by a PBS2 delete. 
 
These data suggest that Sch9p and Hog1p are involved in the same pathway that 
regulates neutral lipid accumulation, as no additive effect was observed. If these 
proteins had been involved in separate pathways, a further reduction in neutral lipid 
levels would be expected. If multiple pathways involved in lipid homeostasis are 
affected (e.g. lipid production and lipid degradation) then you would expect a different 
phenotype than if one is (e.g. if lipid production is reduced and degradation increased 
you’d expect less lipid accumulation than if just lipid production were reduced). 
 
3.6 Deletion of MSN2/4 and DGA1 result in a reduction of neutral lipid levels 
Hog1p is important for regulating neutral lipid accumulation but it is unknown if it acts 
directly or has downstream targets. Two potential targets are the transcription factors 
Msn2/4 and the diacylglycerol acyltransferase Dga1p. Msn2/4p are transcription factors 
that are known to be targets of Hog1p. Dga1p is a diacylglycerol acyltransferase and 
so is involved in neutral lipid synthesis and is involved in neutral lipid accumulation 
(Rostron et al 2015). It spans the ER membrane and is localised there (Liu et al 2011). 
 
An msn2/4 strain had been previously obtained from the NBRP. However, a genomic 
dga1 strain was not available and had to be made via homologous recombination 
using a DGA1 NAT deletion cassette.  A DGA1 deletion cassette was successfully 
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amplified (Figure 3.21 A) and integrated into wild type (Figure 3.21 B). A dga1Δ growth 
curve showed no significant difference of growth relative to the wild type (Figure 3.23). 
A msn2/4Δ growth curve showed comparable growth relative to the wild type (Figure 
3.22). A Nile red assay was then performed to determine levels of neutral lipid in these 
single mutants compared to wildtype cells. The Nile red data (Figure 3.24) showed a 
significant decrease of 1.6-fold in neutral lipid accumulation in dga1Δ and in msn2/4Δ 
cells. The controls lro1Δ and fat1Δ accumulated lipid as expected. 
 
To confirm that deletion of DGA1 was responsible for the decrease in lipid 
accumulation, a wild type copy of DGA1 was reintroduced on a pRS316 plasmid into 
the dga1Δ mutants. 
 
A. 
 
B. 
 
 
 
C. 
 
 
Figure 3.21. Deletion of genomic copy of DGA1 (A) 1% agarose gel displaying 
amplification of a dga1 deletion cassette utilising Dga1 S1 and S2 primers with a 
pFA6aNatMX6 template. Product was ~1.5kb in lanes 1 and 2, lane 3 was a negative 
control. (B) Confirmation of DGA1 deletion in wildtype cells. 1% agarose gel displaying 
PCR results of gDNA amplification with Dga1 forward and NAT reverse primers 
showing successful integration of dga1 deletion cassette into wild type cells (L2-6). 
Product size expected was ~3.5kb in lanes 2 – 6, negative control in lane 1. (C) 
Confirmation of DGA1 deletion in hog1Δ and pbs2Δ cells. 1% agarose gel displaying 
PCR results of gDNA amplification with Dga1 forward and NAT reverse primers 
showing successful integration of DGA1 deletion cassette into hog1Δ (lanes 1 – 2) and 
pbs2Δ cells (lanes 5 - 7). Product size expected was ~3.5kb. 
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Figure 3.22. Growth curve of S. cerevisiae wild type and msn2/4Δ under normal 
conditions in yeast nitrogen base medium (YNB). Cultures were diluted to 2 x 106 
cells (OD595 ~0.1) and incubated with shaking, 180rpm, at 30oC. Optical density 
readings at 595nm were taken hourly until mid to late stationary phase was reached. 
 
 
 
Figure 3.23. Growth curve of S. cerevisiae wild type and dga1Δ under normal 
conditions in yeast nitrogen base medium (YNB). Cultures were diluted to 2 x 106 
cells (OD595 ~0.1) and incubated with shaking, 180rpm, at 30oC. Optical density 
readings at 595nm were taken hourly until mid to late stationary phase was reached. 
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Figure 3.24. Neutral lipid fluorescence intensity of Nile Red stained S. cerevisiae 
wild type and HOG component mutants. Cells were harvested 18 hrs post 
resuspension in YNB. Cells were washed twice in PBS before adjusting to a cell 
density of 2 x 107 cells/ml. 5 x 106 cells were transferred to the wells of black 96-well 
plates in triplicate. 25μl PBS/DMSO (1:1 v/v) and 5μg/ml Nile red were added to each 
sample. Plates were screened using the wavelengths: excitation 485nm, emission 
535nm. Data shown as means of duplicates ±SD. Significance indicated between wild 
type and dga1Δ and lro1Δ. * p≤0.1, ** p≤0.01 . Data analysed by one way ANOVA with 
Tukey post hoc test. 
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Figure 3.25. Cloning of DGA1 (a) 1% agarose displaying gel extraction of 
amplification of DGA1 from Wild Type S. cerevisiae gDNA using Dga1 For and Dga1 
Rev primers using Phusion polymerase. Products were of the expected size of ~2.2kb 
Lanes 1 through 3 contained the gel extracted DGA1. (b) 1% agarose gel displaying a 
restriction enzyme digest of pRS316dga1, with banding occurring at ~5kb and ~2 kb as 
is expected for pRS316 (4.8kb) and dga1 (2.2kb). (C)Neutral lipid fluorescence 
intensity of Nile Red stained S. cerevisiae wild type and dga1Δ mutants which have 
had plasmids carrying the dga1 gene added to assess if this restores wild type 
phenotype, a control of empty plasmid (p313) was used. Cells were harvested 18 hrs 
post resuspension in YNB. Cells were washed twice in PBS before adjusting to a cell 
density of 2 x 107 cells/ml. 5 x 106 cells were transferred to the wells of black 96-well 
plates in triplicate. 25μl PBS/DMSO (1:1 v/v) and 5μg/ml Nile red were added to each 
sample. Plates were screened using the wavelengths: excitation 485nm, emission 
535nm. Data shown as means of duplicates ±SD. Significance indicated between wild 
type and dga1Δ and dga1ΔpRS316. **** p≤0.001. Data analysed by one way ANOVA 
with Tukey post hoc test. 
 
DGA1 was successfully amplified by PCR using wild type S. cerevisiae genomic DNA 
(Figure 3.25 A). The amplified DGA1 was the successfully cloned into the yeast vector 
pRS316 (Figure 3.25 B) and transformed into dga1Δ deletion cells. This was then 
sequenced by Source BioScience to confirm insertion (Appendix 1). Nile Red data 
(Figure 3.25 C) showed no significant change in neutral lipid accumulation in between 
control wild type cells transformed with pRS316 and wild type cells containing 
pRS316DGA1. In dga1Δ cells containing the control vector, pRS316, a significant 
decrease in neutral lipid accumulation of ~2 fold was observed. However, when dga1Δ 
cells contained pRS316DGA1, neutral lipid levels returned to those seen in the wild 
type. This data confirms that the neutral lipid phenotype observed in the dga1Δ strain is 
the result of loss of DGA1. 
 
These data suggest that both Msn2/4p and Dga1p are involved in neutral lipid 
accumulation. 
 
3.7 Dga1p appears to be a downstream target of Hog1 
As data suggests Dga1p is involved in neutral lipid accumulation it is possible that it 
could be a direct or indirect target of Hog1p. 
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Double delete mutants were created using a DGA1 Nat deletion cassette, resulting in 
hog1Δdga1Δ and pbs2Δdga1Δ mutants. Cassette was amplified and transformed into 
cells (Figure 3.21 A) PCR confirmed integration of the deletion cassette into hog1Δ and 
pbs2Δ cells (Figure 3.21 C). A pbs2 double delete mutant was created as neutral lipid 
accumulation seems to take place independently of Pbs2p (Figure 3.7), so it would be 
expected that there would be no additional effect to neutral lipid accumulation in the 
double delete. Growth Curves (Figure 3.26 and Figure 3.27) show no significant growth 
differences between the double delete mutants, and wild type cells. A Nile Red assay 
was performed after characterisation of the growth of the mutants relative to wild type. 
 
Figure 3.26. Growth curve of S. cerevisiae wild type and hog1Δdga1Δ under 
normal conditions in yeast nitrogen base medium (YNB). Cultures were diluted to 2 
x 106 cells (OD595 ~0.1) and incubated with shaking, 180rpm, at 30oC. Optical density 
readings at 595nm were taken hourly until mid to late stationary phase was reached. 
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Figure 3.27. Growth curve of S. cerevisiae wild type and pbs2Δdga1Δ under 
normal conditions in yeast nitrogen base medium (YNB). Cultures were diluted to 2 
x 106 cells (OD595 ~0.1) and incubated with shaking, 180rpm, at 30oC. Optical density 
readings at 595nm were taken hourly until mid to late stationary phase was reached. 
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Figure 3.28. Neutral lipid fluorescence intensity of Nile Red stained S. cerevisiae 
wild type and HOG component mutants. Cells were harvested 18 hrs post 
resuspension in YNB. Cells were washed twice in PBS before adjusting to a cell 
density of 2 x 107 cells/ml. 5 x 106 cells were transferred to the wells of black 96-well 
plates in triplicate. 25μl PBS/DMSO (1:1 v/v) and 5μg/ml Nile red were added to each 
sample. Plates were screened using the wavelengths: excitation 485nm, emission 
535nm. Data shown as means of duplicates ±SD. Significance indicated between wild 
type and the hog1Δ, pbs2Δ single and double delete mutants. ** p≤0.01. Data analysed 
by one way ANOVA with Tukey post hoc test. 
 
Nile red data (Figure 3.28) shows wild type levels of neutral lipid in the pbs2Δ strain, as 
previously described. Both the single (dga1Δ and hog1Δ) and double deletion 
(hog1Δdga1Δ and pbs2Δdga1Δ) strains, showed a significant neutral lipid decrease 
between 1.7 and 2-fold.  
 
These data suggest that Dga1p is on the same pathway of Hog1p. Neutral lipid 
accumulation in the hog1Δdga1Δ mutant is similar to that of dga1Δ and hog1Δ 
mutants; no additive effect is seen as would be expected if Hog1p and Dga1p acted via 
separate pathways. pbs2Δdga1Δ neutral lipid accumulation is similar to that of dga1Δ 
and hog1Δ mutants, given that pbs2Δ did not accumulate less neutral lipid than wild 
**       **        **          **  
78 
 
type it is likely that the decrease in the pbs2Δdga1Δ mutant is due to the deletion of 
DGA1 and the deletion of PBS2 has no effect on neutral lipid accumulation. 
 
3.8 Dga1p contains 4 potential MAPK sites 
 
As data suggests that Hog1p and Dga1p on the same pathway (Figure 3.28), Dga1p is 
a potential target of Hog1p. Hog1p activates proteins via phosphorylation at conserved 
sites (S/T P), Dga1p has four of these sites. These sites were mutated to try to identify 
which (if any) are required for neutral lipid accumulation. If these sites (or a site) are 
required then it may suggest that Hog1p is regulating neutral lipid accumulation via 
phosphorylation, this could be confirmed by immunoprecipitation which would show a 
direct interaction between the proteins. 
 
Potential MAPK sites were identified by analysing protein sequence data curated by 
Uniprot and Saccharomyces genome database, specifically looking for S/T P sites in 
the amino acid sequence, four where identified. These sites were mutated to prevent 
phosphorylation by changing the serine or threonine to an alanine, which cannot be 
phosphorylated.  
 
  1 MSGTFNDIRR RKKEEGSPTA GITERHENKS LSSIDKREQT LKPQLESCCP LATPFERRLQ  
 61 TLAVAWHTSS FVLFSIFTLF AISTPALWVL AIPYMIYFFF DRSPATGEVV NRYSLRFRSL  
121 PIWKWYCDYF PISLIKTVNL KPTFTLSKNK RVNEKNYKIR LWPTKYSINL KSNSTIDYRN  
181 QECTGPTYLF GYHPHGIGAL GAFGAFATEG CNYSKIFPGI PISLMTLVTQ FHIPLYRDYL  
241 LALGISSVSR KNALRTLSKN QSICIVVGGA RESLLSSTNG TQLILNKRKG FIKLAIQTGN  
301 INLVPVFAFG EVDCYNVLST KKDSVLGKMQ LWFKENFGFT IPIFYARGLF NYDFGLLPFR  
361 APINVVVGRP IYVEKKITNP PDDVVNHFHD LYIAELKRLY YENREKYGVP DAELKIVG 
 
Figure 3.29. Potential MAPK phosphorylation sites (S/T P) in the N terminus of 
Dga1p indicated in bold, underlined and red. (Phosphorylation sites were determined 
from data curated by Uniprot and Saccharomyces genome database.) 
 
The intent was to mutate each of these sites (S17, T53, T84 and S103) to get single 
point mutation variants of the protein. These single mutants would then be used to 
make multiple residue mutant variations (e.g. S17 + T53, or all 4 together). These 
mutated DGA1 genes would then be cloned into a pRS316 plasmid and transformed 
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into a dga1Δ mutant. As reintroduction of wild type DGA1 restores phenotype it would 
be expected that these mutants would also restore phenotype, unless the sites mutated 
are essential for lipid accumulation. Use of multi residue mutants would allow the 
identification of sites that may be phosphorylated together to allow for neutral lipid 
accumulation (e.g. an S17 mutant may accumulate lipid just fine, as may a T53 mutant, 
but an S17 T53 mutant may not). Deletion mutants with these mutated DGA1’s 
integrated via plasmid would then be assayed by the Nile Red method to determine 
neutral lipid levels. The QuikChange method and extended primer PCR methods were 
attempted to create these mutants. Mutation of DGA1 was unsuccessful with both 
methods tested  
 
3.9 Tagged DGA1 is not detectable by Western Blotting 
 
Dga1p is involved in neutral lipid accumulation, a potential point of interest was the 
amount of Dga1p in cells as the lipogenic switch occurred. We were interested in what 
happens to Dga1p during the lipogenic switch in terms of interaction with other 
proteins, the levels of protein and any posttranslational modifications that occur to the 
protein. Of particular interest is the potential interaction between Dga1p and Hog1p. 
This would require DGA1 to be tagged to allow for detection, as such Dga1p was C 
terminally tagged with a HA tag. Tagged DGA1 would be required to determine its 
phosphorylation state and to perform immunoprecipitation to assess Dga1p’s 
interaction with Hog1p. 
 
A DGA1-3HA tagging cassette was made via PCR as described in 2.3.1.2 and 
transformed into wild type, hog1Δ and pbs2Δ cells as described in 2.4.1.3. The DGA1-
3HA tagging cassette was successfully amplified (Figure 3.30 A), a product of the 
appropriate size (~1500bp) was produced using the primers Dga1 S2 and S3 which 
amplify and 3’ HA tag the DGA1 from gDNA. PCR was performed with a and Nat REV 
primers, this would only amplify a product if DGA1 had been tagged as the wild type S. 
80 
 
cerevisiae does not contain a site for the Nat REV primer to bind to. This PCR 
confirmed it had successful integrated into wild type (Figure 3.30 B), hog1Δ and pbs2Δ 
cells (Figure 3.30 C) as amplification was seen in some colonies, these colonies were 
the ones used for further work. Protein extraction of cells were performed and run on a 
polyacrylamide protein gel to determine whether the tagged protein could be detected 
by western blot using a 3HA antibody and its associated secondary antibody, which 
allowed for visualisation using ECL reagents.   
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Figure 3.30. Genomic tagging of DGA1. (A) 1% agarose gel displaying amplification 
of a DGA1 3HA tagging cassette utilising Dga1 S2 and S2 primers with a 
pFA6aNatMX6 template, product was ~1.5kb. Lanes 1 and 2 are the cassette, lane 3 is 
a negative control. (B) 1% agarose gel displaying PCR results of gDNA amplification 
with Dga1 forward and NAT reverse primers showing successful integration of 3HA-
dga1 tagging cassette into Wild Type S. cerevisiae cells (lanes 1-8). Product size 
expected was ~3.5kb. (C) 1% agarose gel displaying PCR results of gDNA 
amplification with Dga1 forward and NAT reverse primers showing successful 
integration of 3HA-dga1 tagging cassette into hog1Δ and pbs2Δ cells. Product size 
expected was ~3.5kb. Lane 1 is a negative control (wild type gDNA), lanes 2 – 4 are 
hog1Δ lanes 5 – 7 are pbs2Δ. 
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Figure 3.31. A) Western blot of protein extractions from dga1-3HA tagged S. 
cerevisiae (L1 – L18 [lanes 1 – 8 were protein extractions from a cell with an 
integrated tagging cassette, lane 9 was from wild type control; lanes 10 – 17 were 
protein extractions from a cell with an integrated tagging cassette, lane 18 was from 
wild type control]) at 8 hours of growth in YNB media and incubated with shaking, 
180rpm, at 30oC. Membranes were probed with α-3HA, an ECL secondary antibody 
was added to the primary antibody to allow for visualisation on a Biorad™ ChemiDoc™ 
XRS+ machine. B) Western blot of protein extractions from dga1-3HA tagged S. 
cerevisiae (L1 – L18 [lanes 1 – 8 were protein extractions from a cell with an 
L1       L2     L3   L4                       L5     L6      L7     L8 
L1  L2   L3  L4  L5  L6   L7  L8  L9              
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integrated tagging cassette, lane 9 was from wild type control; lanes 10 – 17 were 
protein extractions from a cell with an integrated tagging cassette, lane 18 was from 
wild type control]) at 8 of growth in YNB media and incubated with shaking, 180rpm, at 
30oC. Membranes were probed with α-3HA, an ECL secondary antibody was added to 
the primary antibody to allow for visualisation on a Biorad™ ChemiDoc™ XRS+ 
machine. C) Western blot of protein extractions from dga1-3HA tagged S. 
cerevisiae (L1 and L5), wild type Schizosaccharomyces pombe (L2, L3, L6 and L7) 
and S. pombe 429 atf21-3HA::kan pcr1::ura4 cells (L4 and L8) at 8 of growth in YNB 
media and incubated with shaking, 180rpm, at 30oC. Membranes were probed with α-
3HA, an ECL secondary antibody was added to the primary antibody to allow for 
visualisation on a Biorad™ ChemiDoc™ XRS+ machine. 
 
Figure 3.31 A – C shows that 3HA tagged Dga1p was not detectable by western, with 
no clear band being detected at 47kDa, the expected size of 3HA tagged Dga1p. 
Control lanes were run in all gels (Figures 3.31 A – C). In the case of Figures 3.31 A 
and B wild type controls were used in the last lane, these did not show any difference 
compared to the tested samples. Controls of Schizosaccharomyces pombe (S. pombe) 
wildtype and atf21-3HA::kan pcr1::ura4 cells as well as untagged S. cerevisiae were 
used on Figure 3.31 C and did not show any difference to that of the tagged wild type 
cell; these were used due to the inability to detect 3HA tagged Dga1p from tagged cell 
protein extractions in Figures 3.31 A and B. 
 
This western data suggested no detection of the 3HA tagged Dga1p. It is possible that 
there is an issue with either the primary HA antibody or the secondary antibody, with no 
detection with extractions of cells that contain the 3HA cassette or from S. pombe 
samples which has Atf21p genomically tagged with 3HA.  
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4.0 Discussion 
 
The MAPK Hog1 is required for neutral lipid accumulation 
Lipid accumulation occurs in cancer cells due to the change in cellular metabolism, 
predominantly through the Warburg effect (Warburg 1925; Warburg 1956), which is 
driven by a need for the cells to keep growing rapidly in a tumour environment (Esechie 
et al 2009). Understanding the regulation of lipogenesis is important as it allows for a 
better understanding of cancer progression and rate of growth (as the Warburg effect 
alters metabolism so cancer calls accumulate lipid). It also creates a potential target for 
therapy (Liu et al 2017) as lipogenesis is important to cancer cell function and for 
sustaining their rapid growth (Hanahan et al 2011). Suppression or cessation of 
lipogenesis may prove to be an effective treatment to either slow growth rate (and so 
allow for more effective surgical removal of the cancer) or cause cancer cell death 
(either by disrupting metabolism so much as to cause death or by making energy so 
limited as to prevent cancer cells from supressing the immune system. Mammalian 
cells are expensive and difficult to work with so the use of a model organism with high 
homology is desirable. S. cerevisiae is a well-established model organism (Zhang et al 
2003; Henry et al 2012) with many conserved pathways with that of mammalian cells; 
normal S. cerevisiae cells naturally accumulate lipid under conditions of nitrogen 
limitation (Natter et al 2013). (Siepel et al 2005; Hamza et al 2015). As such it was 
used in this study to investigate regulation of lipid accumulation by the homologue of 
p38 MAPK pathway, the HOG MAPK pathway (Hay et al 2004; Dann and Thomas  
2006; Loewith et al 2011). 
  
The data in Figure 3.1 suggest that Hog1p has a key role in neutral lipid accumulation. 
However, other HOG pathways components upstream of Hog1p (Ssk2p, Ste11p and 
Pbs2p) don’t have an obvious role, with their deletion not affecting accumulation of 
neutral lipids.  
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The role of Hog1p in lipid accumulation has been supported by data from mammalian 
cells withp38, the homologue of Hog1p, playing an important role in the regulation of 
neutral lipids accumulation in macrophages (Mei et al 2012). p38 inhibits 
macroautophagy by suppression of the key macrophage autophagy gene, ulk1. Once 
p38 is activated the ratio of cholesterol esters over free cholesterol increased in favour 
of the cholesterol esters (Mei et al 2012).  Due to the high homology between S. 
cerevisiae and mammalian lipid metabolism (Carman et al 2007; van Meer et al 2008; 
Nielsen 2009) and MAPK pathways (Waskiewicz et al 1995; Banuett 1998; Wagner et 
al 2009) it is possible that Hog1p dependent regulation of lipid metabolism is occurring 
in S. cerevisiae. 
 
The Hog1p homologue in S. pombe, Sty1p, has been implicated in the storage of 
neutral lipid in lipid droplets and for controlling the levels of triacylglycerol (Grimard et al 
2008), with evidence suggesting that MAPK regulation of lipid storage and that this is 
conserved in other eukaryotes (Grimard et al 2008). Grimard et al 2008 utilised an 
sty1Δ in combination with a lipase inhibitor (thus preventing lipid degradation) and it 
was concluded that Sty1p (and JNK2) play a role in lipid degradation regulation rather 
than biosynthesis. The use of a lipid inhibitor however is a significant departure from 
the methodology used in this study and may explain why no decrease in neutral lipid 
was observed in the deletion strains used in that study. 
 
Given the high level of conservation of the MAPK pathway between mammalian, fission 
and budding yeast it is that the same is true for Hog1p as for Sty1p, that Hog1p is 
involved in the regulation of lipid degradation. Perhaps it directly or indirectly regulates 
lipase inhibition and so its deletion from a cell (and no inhibition of lipase activity) would 
increase the degradation of neutral lipid; if more lipids are being degraded then a cell 
will accumulate less of them. 
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Other MAPK pathways are known to regulate lipid homeostasis for example, the cell 
way integrity MAPK pathway which regulates responses to cell membrane and cell wall 
stress (Nunez et al 2008).  In certain environmental conditions levels of phospholipids, 
through regulation of their turnover and synthesis, are affected by this pathway (Nunez 
et al 2008). The cell wall integrity MAPK Slt2p (Mpk1p) has an essential role in the 
regulation of lipid homeostasis with slt2Δ (mpk1Δ) cells showing altered lipid 
metabolism, including the accumulation of neutral lipids, phosphatidylcholine, 
diacylglycerol and triacylglycerol (Nunez et al 2008). This suggests a negative 
regulatory role of lipid accumulation for Slt2p, in opposition to the data obtained for 
Hog1p. However, in their experimentation media was supplemented with inositol and 
choline. Inositol is a phospholipid precursor, and elicits a stress response from the cell 
(Henry et al 2014). When inositol is added to yeast media the synthesis of the 
phospholipid phosphatidylinositol increases significantly, and more of it is accumulated 
in the cell (Loewen et al 2004; Gaspar et al 2006; Gaspar et al 2011). This would result 
in phospholipid accumulation in significant excess even in wild type cells which may 
affect the neutral lipid phenotype. Choline was also added to the growth media, it has 
long been recognised as improving growth rates of cells (Nagle 1969) and is 
recognised as an essential nutrient for mammals (Zeisel et al 2009) and fungi 
(Markham et al 1993). Increased growth rates would result in less time needed to reach 
stationary phase. To determine if this research data is applicable experiments (all those 
done in this study) would have to be redone with inositol and choline added to growth 
media to eliminate them as contributing factors (which they are likely to be due to how 
they affect cellular metabolism). Slt2p has been found to interact with Hog1p in the 
process of mitophagy under heat and nitrogen starvation stress conditions and was 
determined experimentally via the use of fluorescently tagged proteins and 
fluorescence microscopy in various mutants including hog1Δ (Mao et al 2011; 
Córcoles-Sáez et al 2012), therefore it is possible that Hog1p may act via Slt2p or Stl2p 
may act via Hog1p. Experiments utilising GFP tagged variants of these proteins may 
allow for visualisation of co-localisation within the cell. The use of immunoprecipitation 
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may allow for the identification of this interaction if it is acting directly in this case (if 
indeed it is acting at all in lipid accumulation). Slt2p also interacts with other HOG 
pathway components such as Ssk2p, Ste11p and Pbs2p (Aronova et al 2007; Torres et 
al 2002; Chan et al 2000; Reinke et al 2004; Breitkreutz et al, 2010; Soulard et al 2010; 
Wang et al 2011), and with some of Hog1p’s target Msn2/4 (Sharifpoor et al 2012) 
Interactions between Slt2p and the upstream components of the HOG pathway may 
suggest Slt2p indirectly interacts with Hog1p, through its MAP2K, MAP3K or MAP4K. 
Double deletion hog1Δslt2Δ mutants could be created and their neutral lipid levels 
compared with the single deletion mutants to see if phenotype is rescued which is the 
expected phenotype if they do not interact as Hog1p positively regulates lipid 
accumulation and it would appear, though work in normal media would have to be 
performed to confirm, that Slt2p negatively regulates lipid accumulation. 
 
Regulation of neutral lipid accumulation via Hog1p is Pbs2p independent. 
 
If Hog1p is involved in neutral lipid accumulation we would expect to observe activation 
of the protein. Hog1p is typically activated by dual phosphorylation on Thr174 and 
Tyr176 (Maayan et al 2012), which can be detected via an α-P-p38 antibody via 
western blot analysis. This allows for the analysis of the phosphorylation state of 
Hog1p during different phases of growth. 
 
Figure 3.9 shows that in the early exponential phase samples (6 – 7.5 hours) Hog1p is 
dually phosphorylated at Thr174 and Tyr176 before moving into mid exponential phase 
(8 – 8.5 hours) where phosphorylation is lost, indicating a lack of activation of Hog1p. 
In late exponential (9 – 10 hours) Hog1p is phosphorylated again as cells move 
towards stationary phase. This data suggests an activation of Hog1p, via 
phosphorylation, as cells approach stationary phase wherein they begin to accumulate 
neutral lipid due to nitrogen limitation in the growth media (Henry et al 1973; Behalova 
et al 1992; Natter et al 2013). 
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Hog1p is phosphorylated in early exponential phase due to its role in G1 and G2 cell 
cycle progression, cells are rapidly dividing. This phosphorylation is lost in late 
exponential phase due to it no longer being needed as excessive Hog1p activation is 
lethal to cells due to long term stresses arresting cell division and leading to apoptosis 
(Brewster et al 1993; Zhan et al 1999). Hog1p is rephosphorylated upon entry into 
stationary phase, likely as a result of nutrient limitation stress in stationary phase 
(Smith et al 2004). Therefore, could the activation of Hog1p by dual phosphorylation 
seen in late exponential phase be due to the lipogenic switch or due to the nutrient 
limitation stress occurring as nitrogen is depleted from the media. 
 
Both nitrogen and carbon limitation exert stress on S. cerevisiae (Aoki et al 2011) and 
either one of these (most likely the nitrogen limitation) could explain the 
phosphorylation seen, in essence the dual phosphorylation of Hog1p observed could 
be as a result of nitrogen nutrient limitation. This is supported by Aoki et al 2011 who 
found Hog1p being dually phosphorylated in response to nitrogen limitation (Aoki et al 
2011). This is further supported by Smith et al 2002 who describes that the Hog1p 
homologue, Sty1p, in S. pombe is dually phosphorylated by Wis1p (the S. pombe 
homologue of Pbs2p) in response to nutrient limitation. If the phosphorylation observed 
in Hog1p in late exponential is the result of nitrogen limitation, the question arises is 
this required for neutral lipid accumulation? To determine this, initial experiments were 
undertaken to measure neutral lipid levels in pbs2 cells.  
 
Hog1p is classically activated by Pbs2p phosphorylation at Thr174 and Ty176 (Maayan 
et al 2012) in response to conditions of hyperosmotic stress and of nitrogen limitation 
(de Nadal et al 2002; Aoki et al 2011). However, accumulation of neutral lipids in a 
pbs2Δ mutant were shown to be similar to the wild type (Figure 3.7). This indicates that 
Pbs2p is not required for lipid accumulation, however, is this reflected in the 
phosphorylation pattern of Hog1. Western blot analysis of Hog1p phosphorylation in a 
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pbs2 strain compared to wildtype, demonstrates that the dual phosphorylation of 
Hog1p at Thr174 and Tyr176 in completely lost during all growth phases (Figure 3.12). 
 
Data also suggests that the dual phosphorylation at Thr174 and Ty176, observed 
during late exponential phase in wild type cells, is as a result of Pbs2p in conditions of 
nitrogen limitation (Maayan et al 2012). As such, this dual phosphorylation by Pbs2p in 
late exponential phase doesn’t appear to be essential for lipid accumulation and 
suggests activation of Hog1p via an alternative mechanism. 
 
There is evidence from the literature that Hog1p can be activated/phosphorylated via 
different mechanisms; e.g. via the kinase Pbs2p (Rodriguez-Pena et al 2010) or 
potentially via autophosphorylation (Maayan et al 2012). 
 
Using a genetic screen, several hyperactive mutants of Hog1p were identified (Bell et 
al 2001). A number of these mutants were in the L16 domain, in Hog1p the region 
P309 to R358, which is highly conserved among Hog1p homologues. Some of these 
sites are Pb2p independent such as sites F318L and F318S. The identification of these 
sites raised the question, if these sites allow Pbs2p independent Hog1p activation then 
kinase is phosphorylating these Pbs2p independent sites? These sites could be 
phosphorylated by Hog1p, via autophosphorylation (Maayan et al 2012). Further work 
has been done with the sites Y68H, D170A, F318L, F318S, W320R, F322L, and 
W332R identified in Bell et al 2001; these sites have been shown to be activated in a 
Pbs2p independent manner (Bell et al 2001). The sites D170A, F318S and F318L have 
been shown autophosphorylated (Maayan et al 2012). The C-terminal regulatory region 
(between Y337 and F343) of Hog1p has been suggested to be responsible for 
autophosphorylation ability (Maayan et al 2012). This site overlaps with the Pbs2-
interacting site, and is required for Pbs2p dependent activation of Hog1p (Maayan et al 
2012). The site L341 seems to be essential to this autophosphorylation ability, 
truncation of the protein C-terminal region beyond L341 prevents Hog1p activity ion 
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pbs2Δ cells. However, the amino acid itself does not appear to matter as mutation of 
L341 to A341 did not affect the autophosphorylation ability of Hog1p in a pbs2Δ cell.  
This region appears to be evolutionary conserved in the mammalian orthologue of 
Hog1p, p38α, a deletion of Y342 to F348 removes p38α’s ability to autophosphorylate. 
This may explain the neutral lipid accumulation observed in the pbs2Δ cells.  
 
Hog1p could be activated despite lacking the dual phosphorylation at Thr174 and 
Ty176 that Pbs2p dependent activation requires. Autophosphorylation at a previously 
uncharacterised site or at one of the two Pbs2p dependent sites (Thr174 and Ty176) 
may suffice; this would not be detectable by the α-P-p38 antibody and so would be in 
line with the results observed (Figure 3.9). 
 
In addition, a large scale phosphoproteomic analysis of S. cerevisiae, from cells at 
grown in YPD media until an A600 of 0.7 was reached, then treated with 0.05% methyl 
methanesulfonate for 3 h, has identified two further phosphorylation sites in Hog1p, 
Ser178 and Thr179 (Albuquerque et al 2008). Either of these sites could be involved in 
activation of Hog1p during neutral lipid accumulation, however, it would need to be 
established if these sites are Pbs2p independent. 
 
Having determined that dual phosphorylation of Hog1p at Thr174 and Ty176 was not 
required for neutral lipid accumulation and, based on previously published data, 
experiments were conducted to determine if other potential phosphorylation sites could 
be detected. Phos-tagTM has been utilised extensively and successfully by many 
researchers (Oh et al 2008; Yang et al 2010; Aokia et al 2011; Aguilar et al 2011; 
Hukkelhoven et al 2012; Ban et al 2013; Longoni et al 2015; Kinoshita et al 2017) to 
separate protein isoforms based on the number of phosphorylation sites (Kinoshita et 
al 2009). The Phos-tagTM nanomolecule acts by binding to anionic substituents as seen 
in phosphorylated proteins, with the phosphate groups holding the negative charge 
(Kinoshita et al 2009). This slows the progression of phosphorylated proteins through 
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an acrylamide gel, allowing a separation of proteins by phosphorylation states (more 
phosphorylated sites mean more places on a protein for Phos-tagTM to bind to). 
As such, a Phos-tagTM gel was used to determine whether any other phosphorylation of 
Hog1p could be observed in the absence of Pbs2p. In each case, wild type controls 
were included to ensure that the Pbs2p dependent dual phosphorylation of Hog1 could 
be observed.  Further, all samples were run on protein gels without Phos-tagTM to 
confirm the presence of Hog1p.  
 
In all cases, the protein gels without Phos-tagTM,total Hog1p was detected in both the 
wildtype and pbs2 samples. Further, the dually phosphorylated form of Hog1p was 
observed in the wildtype, but not the pbs2 samples. However, following western blot 
analysis of, the Phos-tagTM gels, no signal was detected with the α-P-p38 antibody 
(Figure 3.13 A) with samples that had previously worked in the absence of Phos-tagTM 
(Figure 3.13 B). With the α-hog1 antibody, a faint signal was detected, although not to 
the extent seen with the non- Phos-tagTM gels. (Figure 3.13.2 ). Due to the lack of 
detection of Hog1p, both the total and phosphorylated form, using the Phos-tagTM gels 
no conclusions could be made about Pbs2p independent phosphorylation state of 
Hog1p during the lipogenic switch. 
 
The α-P-p38 and α-hog1 antibodies had both worked well on regular gels so the 
antibodies themselves were not the issue. Given that the same protein samples that 
were used worked well in the absence of Phos-tagTM, it is unlikely that these impacted 
on the result. Given that Phos-tagTM gels have been used extensively so it is likely that 
the preparation of these Phos-tagTM gels needed to be optimised for the epitopes for 
the Hog1p and α-P-p38 antibody were masked on Hog1p when it was run on the Phos-
tagTM gel. 
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The manganese method (see 2.5.4 Phos-tagTM) was the only one attempted during this 
study, however Kinoshita et al 2011 describes a zinc based method that can separate 
some phosphoprotein isoforms which the manganese method cannot. It is possible that 
Hog1p is one of these proteins whose isoforms cannot be separated using the 
manganese method, however a clear band should still be visible with all of the Hog1p 
isoforms together in one band.  
 
Alternative methods for the detection of phosphorylation sites exist such as mass 
spectrometry. Chi et al 2007 used electron transfer dissociation mass spectrometry to 
identify phosphorylation sites on proteins from S. cerevisiae. They identified over 1200 
phosphorylation sites on over 600 proteins, with a variable expression range of proteins 
from very low levels (<50 of that protein per cell) to very highly expressed proteins 
(>1,000,000 copies per cell). The use of protein immunoprecipitation, using the Hog1 
antibody, would eliminate issues encountered with proteins recovered from crude cell 
extractions (Dephoure et al 2013), ensuring increased purity of the protein where it may 
otherwise be in low relative abundance in the cell. Ho et al 2002 purified S. cerevisiae 
proteins using immunoprecipitation before utilising mass spectrometry. 
 
However, mass spectrometry is not inherently quantitative, and with standard 
methodologies gives qualitative results. There has however been much work in the 
development of quantitative mass spectrometry techniques. Keilhauer et al 2015 utilise 
an intensity-based label-free quantitative liquid chromatography–mass spectrometry 
analysis to investigate protein-protein interactions with GFP-tagged proteins and their 
interactors in budding yeast (Keilhauer et al 2015).  
 
2D electrophoresis is another method that can be used to detect phosphorylated 
protein isoforms.  2D electrophoresis has been used to identify multiple phosphorylated 
isoforms of the transcription factor Atf1p in Schizosaccharomyces pombe under 
conditions of stress (Lawrence et al 2007). These phosphorylated isoforms were found 
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to be dependent on Sty1, the S. pombe homologue of Hog1p. As such, a similar 
experiment could be undertaken during the lipogenic switch, to determine the 
phosphorylated isoforms of Hog1p in a wild type and pbs2Δ mutant.  
 
Sch9p is required for neutral lipid accumulation 
 
With respect to neutral lipid accumulation, Hog1p seems to be activated in a Pbs2p 
independent manner. As Hog1p is classically activated by phosphorylation, it is 
possible that an alternative kinase is involved in lipid accumulation in response to 
nitrogen limitation in the environment. Utilising GFP tagged Hog1p would allow for the 
observation of the localisation of Hog1p during the activation of neutral lipid 
accumulation on live cells (Goodwin 1999; Haraguchi et al 2000; Ettinger et al 2014) 
and so to determine if Hog1p is actually being activated during the lipogenic switch. 
This will also indicate if nuclear localisation is required for neutral lipid accumulation. 
 
The TOR pathway regulates cell growth in response to cellular stresses and nutrient 
availability and activates cellular responses such as protein synthesis and gene 
transcription (Hay et al 2004) (Loewith et al 2010). In conditions with plentiful nutrients, 
Tor1p inhibits transcriptional activators such as Msn2/4p by sequestering them within 
the cytoplasm (Crespo et al 2002). In conditions of nitrogen limitation Tor1p activity is 
inhibited, resulting in the release of transcription factors and activation of gene 
transcription (Rødkær et al 2014). It should be noted that TOR component deletion 
mutants have reduced neutral lipid levels indicating the TOR pathway’s role in neutral 
lipid accumulation (Madeira et al 2015). This is highly conserved among eukaryotes, 
with mammalian (Laplante et al 2009b) and plant (Imamura et al 2016) cell orthologues 
of TOR being important for their lipid accumulation. 
 
Sch9p is an AGC family protein kinase, a group of protein kinases whose catalytic 
domains are related to PK1 (Hanks et al 1995), that is a target of Tor1p (Urban et al 
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2007; Wei et al 2009). It is indirectly involved in, among other things, the regulation of 
oxidative and osmotic stresses though Sko1p (Pascual-Ahuir et al 2007). It is also 
involved in nitrogen limitation stress upon its dephosphorylation it acts to change the 
cell’s nitrogen source from ammonium to urea (Urban et al 2007). Sch9 is functionally 
related to protein kinase A and shares phosphorylation targets, such as the MAPK 
Hog1 (Chen et al 2014), and shares a consensus sequence of R[R/K]x[S/T]; 
serine/threonine residues preceded by an arginine at the −3 position and arginine 
/lysine at −2 (Huber et al 2011). Msn2/4p is also a target of Sch9p (Madeira et al 2015). 
 
Data (Figures 3.16 and 3.17) suggests that SCH9 is required for neutral lipid 
accumulation, as a deletion of this gene caused a significant decrease in neutral lipid 
accumulation. The sch9Δ phenotype was rescued when the deletion was 
complemented with pRS313SCH9 (Figure 3.17). This confirms previous data, where 
Nile Red staining was reduced in sch9Δ cells compared to wild type cells (Wei et al 
2009). It is suggested that the decrease in neutral lipids may be due to an increase in 
the activity of the lipolytic enzyme, Tlg2p. Tlg2p has been shown to have lipolytic 
activity towards neutral lipids when expressed in E. coli and in yeast (Van Heusden et 
al 1998), it should be noted that it is localised in the mitochondria (Ham et al 2005), 
while Hog1p and Sch9p are primarily localised in the cytoplasm (Huh et al, 2003). GFP 
tagging of Hog1p and or Sch9p could allow for determining whether they co-localise or 
they localise with Tig2p in the mitochondria. The S. pombe Hog1p homologue, Sty1p, 
has been found in the mitochondria (Di et al 2012) which indicates (due to the high 
level of homology between S. cerevisiae and S. pombe) that this may be occurring in 
S. cerevisiae.   
 
S. pombe contains at least 3 Sch9p homologues, Sck1, Sck2 and Psk1 (Nakashima et 
al 2012), one of which, Sck1, interacts with Sty1 (Ryan et al 2012) supporting the idea 
of an interaction between Hog1p and Sch9p in S. cerevisaie. 
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There is however no evidence from this study to suggest that Hog1p is being 
phosphorylated at all, only that it is activated in a Pbs2p independent manner. While 
Hog1p is classically phosphorylated for activation, this may not be the mechanism of 
activation in the case of neutral lipid accumulation.  
 
Hog1p is a potential target of the  protein kinase, Sch9p 
 
To determine if Hog1p is a target of Sch9 during the lipogenic switch, the neutral lipid 
levels in stationary phase were compared in both single and double deletion mutants of 
HOG1 and SCH9. Both single deletions and double deletions of genes caused a similar 
reduction in accumulated neutral lipids when compared to the wild type (Figure 3.7, 
Figure 3.16 and Figure 3.20). 
 
These data suggest that Sch9p and Hog1p are involved in the same pathway that 
regulates neutral lipid accumulation, as no additive effect was observed. If these 
proteins had been involved in separate pathways, a further reduction in neutral lipid 
levels would be expected. This technique has been used in a number of studies 
including Haber et al 2013 who used it to investigate partially redundant pairs of genes 
in S. cerevisiae and in S. pombe (Roguev et al 2007; Roguev et al 2008; Ryan et al 
2012). This technique has been used to compare the phosphate signal transduction 
pathway in S. cerevisiae (which is well characterised) and S. pombe (which was not 
well characterised), with results suggesting that only the upper most genes share 
similar roles in both yeast species (Henry et al, 2011). 
 
Sch9p has been shown to be involved in the osmostress-regulated transcriptional 
response, acting via the transcription factor Sko1p. Sko1p is also a target of Hog1p 
under osmostress conditions (Pascual-Ahuir et al 2007). Sch9p acts by forming a 
complex with Hog1p, which binds to and phosphorylates Sko1p. There is no evidence 
that Sch9p phosphorylates Hog1p, but it might regulate other proteins in complex with 
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Hog1p. As such without Hog1p, Sch9p can’t bind and activate specific target proteins. 
However, this interaction between Sch9p and Hog1p has only been observed following 
osmotic stress response, so further work would need to be done to determine whether 
this mechanism exists during the accumulation of neutral lipid. 
 
Sch9p also associates to genes in a Hog1p dependent manner, with a complete lack of 
Sch9p localisation to GRE2 and CTT1 in a hog1Δ mutant (Pascual-Ahuir et al 2007). 
This indicates multiple Hog1p dependent actions of Sch9p, of which some may be 
involved in lipid accumulation (Figure 3.7 and Figure 3.16). If Hog1p is absent, 
recruitment of Sch9p to the promoter could not occur, resulting in a similar phenotype 
of a strain lacking Sch9p (as in sch9Δ).  Utilising GFP tagging of Hog1p and Sch9p 
could allow for determination of their localisation upon the lipogenic switch, once 
tagged these proteins can be observed by florescence microscopy of cell samples 
taken throughout the lipogenic switch (e.g. every 30 minutes from 6 to 12 hours). It may 
be possible to determine if it localises at certain promoters using chromatin 
immunoprecipitation (ChIP) could also be performed to determine if these proteins are 
bound to specific gene proteins. If Hog1p and Sch9p are forming a complex and 
localising at the same genes this should result in them precipitating together. The 
hog1Δ and sch9Δ mutants could be used in a ChIP looking to see if the proteins Hog1p 
and Sch9p bound to a promoter of a gene that is associated to in a Hog1p dependent 
manner. Key neutral lipid genes, such as DGA1 and LRO1 (Oelkers et al 2002), are 
potential targets of this complex. Utilising sequence data from Saccharomyces genome 
database the region 1kB upstream of the gene (predicted to contain the promoter) of 
DGA1 and LRO1 were compared using NCIB BLAST to try to identify shared 
consensus site for binding of these proteins. 4 alignments were found (see Figure 4.1). 
Hog1p has been shown to bind to genes with the STRE 5’ CCCCT ‘3 (Varela et al 
1995), this sequence does not occur anywhere 1Kb upstream from DGA1.  
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Figure 4.1 Sequence alignments between DGA1 and LRO1 + 1Kb. Sequence data 
from Saccharomyces genome database. Sequences compared using NCIB BLAST.  
 
To test if Sch9p is interacting with Hog1p an immunoprecipitation (IP) experiment could 
be performed using cell lysates obtained as cells start to accumulate lipid. Sch9p would 
need to be tagged and the Hog1p antibody would be used to pull down proteins in the 
IP assay. The protein extractions would be run on a gel and probed for the tagged 
Sch9, if the proteins are interacting tagged Sch9 would be detected. The proteins could 
then be identified by utilising immunoprecipitation and their relevant antibodies.  
 
Homologues of Sch9p and Hog1p in other organisms have been found to interact. In 
Aspergillus fumigatus, the SchAp (Sch9p) protein modulates SakAp (Hog1p) activity 
under conditions of osmotic stress (de Castro et al, 2016). An increase in SakAp 
phosphorylation in a SchAΔ mutant has been observed, with phosphorylation resulting 
in activation of the kinase. The implications from the data from Aspergillus fumigatus 
would suggest that there should be an equal or increased amount of Hog1p 
phosphorylation in a sch9Δ and equal amounts or increased levels of lipid 
accumulation, this is however not observed in S. cerevisiae (Figure 3.16), indicating 
that A. fumigatus may have significant differences in lipid metabolism regulation.  
 
Dga1 1216  TGTACTCTTCT  1226  
           ||||||||||| 
Lro1 2452  TGTACTCTTCT  2442 
 
Dga1 1639  CTATTCCAAGA  1649 
           ||||||||||| 
Lro1 2471  CTATTCCAAGA  2481 
 
Dga1 1370  TGGAAGTGGTA  1380 
           ||||||||||| 
Lro1 2552  TGGAAGTGGTA  2542 
 
Dga1 2183  GCGGAGTTGAA  2193 
           ||||||||||| 
Lro1 2874  GCGGAGTTGAA  2884 
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There is indication that the S. pombe Sch9p homologue, Sck1p, may be involved in 
response to nutrient availability through the Hog1p homologue Sty1p (Mudge et al 
2014). A similar interaction between Sch9p and Hog1p in response to nutrient stress 
may be occurring in S. cerevisiae due to high level of homology between S. pombe and 
S. cerevisiae. Sck1p acts as an indirect regulator of PKA activity,via Gpa2p. It should 
be noted that Mudge et al 2014 focuses on glucose (carbon) limitation rather than 
nitrogen limitation, however both carbon and nitrogen limitation signals act through the 
Wis1-Spc1/StyI SAPK pathway in S. pombe.  
 
If Sch9 isn’t the activating kinase for Hog1p, alternative proteins could be detected 
using the following technique. Cell samples could be taken throughout the lipogenic 
switch (late expendable to early stationary phase) and lysed. Using a Hog1p antibody 
and coimmunoprecipitation the Hog1 protein and anything its binding will be isolated 
from the cell lysates. This purified protein sample could them be run on a protein gel, 
stained and protein bands analysed using mass spectroscopy (Link et al 1999). 
 
It should be noted that the pbs2Δsch9Δ double delete restored the neutral lipid 
phenotype to wildtype levels (Figure 3.20). This deletion was tested by PCR using 
primers which would detect the SCH9 deletion cassette (Sch9 Up 100 bp and Nat Rev) 
and was confirmed by gel electrophoresis that amplification had occurred indicating 
that the deletion cassette had integrated successfully. To ensure that the deletion 
cassettes were functioning cells grown on selection media for both deletions (First on 
G418 YPD and then NAT YPD), unless both cassettes were present and functional the 
cells would not be able to grow on the selection media (wild type and single deletion 
cells were used as controls and none of them grew). Growth with the pbs2Δsch9Δ 
double delete was observed on both G418 and NAT YPU selection plates indicating 
correct function of the cassette. This suggests that deletion of PBS2 is able to rescue 
the levels of neutral lipids in the cell, suggesting Pbs2p might be a negative regulatory 
of neutral lipid accumulation. However, significantly increased levels of lipid 
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accumulation were not observed in a pbs2Δ mutant (Figure 3.7). The Nile Red method 
itself is able to detect deletion mutants with increased neutral lipid accumulation, as is 
observed with the fat1Δ mutant (Figure 3.7), this has also been demonstrated in the 
literature (Rostron et al 2015). While PCR has confirmed SCH9 deletion the most 
obvious explanation is that SCH9 hasn’t been deleted. This could be confirmed by 
complementing the pbs2 by cloning PBS2 in a plasmid and seeing if the neutral lipid 
levels return to sch9 levels. If the levels reduce (in what is now a sch9 pbs2 mutant 
with Pbs2p inserted on a vector) then this would not only confirm the deletion of SCH9 
it could indicate a possible interaction between Pbs2p and other downstream 
components of lipid metabolism which would need to be investigated further.  
 
In neutral lipid accumulation, Msn2/4p and Dga1 are potential downstream 
targets of Hog1p 
 
As Hog1p activation is required for neutral lipid accumulation, potential downstream 
targets need to be identified. Once activated, Hog1p can act either directly by 
phosphorylating targets (either in the cytoplasm or nucleus) or indirectly by 
translocating to the nucleus and recruiting RNA polymerase II to target gene promoters 
(Ferrigno et al 1998, Alepuz et al. 2001). 
 
The Nile red assay indicates that neutral lipid levels are reduced in both dga1Δ and 
msn2/4Δ cells when compared to wildtype cells, suggesting a role for both Msn2/4p 
and Dga1p in neutral lipid accumulation (Figure 3.24). There is a clear role for Dga1 in 
lipogenesis, it is a diacylglycerol acyltransferase which is the catalyst for the terminal 
step in triacylglycerol synthesis (Dahlqvist et al 2000). A deletion DGA1 results in a 
decrease in triacylglycerol synthesis and neutral lipid accumulation; this is not 
surprising given the enzymes role in the production of neutral lipid (Oelkers et al 2002, 
Mora et al 2012, Rostron et al 2015).  
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Msn2/4p are transcription factors involved in many pathways such as the oxidative 
stress response and nutrient limitation stress and are known targets of Hog1p (Hasan 
et al 2002, Hohmann 2002). They act by binding to the stress response 
element located in the promoter regions of genes involved in stress response 
(Martínez-Pastor et al 1996).    
 
TOR regulates Msn2/4p in response to nutrient limitation by stimulating their binding to 
BMH2 (a cytoplasmic protein) sequestering them in the cytoplasm (Beck and Hall 
1999). Hog1p is known to interact with Msn2/4p (Alepuz et al 2001; Capaldi et al 2008) 
upon its nuclear localisation, Msn2/4p is a known target of Hog1p (Hohmann 2002).  
 
Msn2/4 is required for lipid accumulation as a reduction in lipid levels is observed in an 
msn2/4Δ mutant (Figure 3.24). This result may also explain why a reduction is 
observed in a hog1Δ mutant as a lack of Hog1p would result in Msn2/4p not being able 
to activate gene transcription of lipid related genes, such as DGA1. If Msn4p isn’t 
activated in a hog1Δ cells, then transcription of DGA1 would reduce and the levels of 
the enzyme would reduce so reducing the amount of lipid accumulated (Oelkers et al 
2002).  Msn2/4 bind to a 5bp STRE, 5’ CCCCT 3’ (Marchler et al 1993; Rodrigues-
Pousada et al 2004). The DGA1 promoter lacks the STRE that Msn2/4 bind to 
therefore Msn2/4 cannot bind directly to DGA1 (based upon sequence data from 
Saccharomyces genome database, Figure 4.2) to induce expression. However, there is 
evidence that Msn4p activates transcription of SFP1 (Split Finger Protein 1), which 
encodes Sfp1, a protein required for transcription of DGA1 (Hu et al 2007). Under 
cellular stress, such as nitrogen limitation, Msn4 activates transcription of SFP1 (Hu et 
al 2007), which encodes Sfp1, which is required for the transcription of DGA1. 
Therefore, in hog1Δ cells, transcription of DGA1 would reduce resulting in a reduction 
of Dga1p and neutral lipid levels (Oelkers et al 2002).  Sfp1p interacts directly with 
TORC1 resulting in Sfp1p phosphorylation. This interaction also acts to negatively 
regulate TORC1 phosphorylation of Sch9p (Lempiaeinen et al 2009).  This indicates a 
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feedback loop which may act to prevent excess Sfp1 and so excess Dga1p. If SCH9 is 
deleted then it cannot complex with Hog1p, this would reduce activation of Msn2/4, 
which would in turn decrease the transcription of SPF1 finally resulting in less Dga1p 
and lipid accumulation. The role of Msn2/4 in lipid accumulation and the inability of 
Msn2/4 to bind to DGA1’s promoter is supported by the literature (Rajvanshi et al 
2017). 
Figure 4.2 DGA1 + 1Kb sequence. The sequence of the stream 1kb before DGA1 
gene based upon sequence data from Saccharomyces genome database. There are 
no points within this sequence which Msn2/4p can bind to meaning that Msn2/4p 
cannot act upon Dga1 transcription directly, but instead (if it is indeed acting upon it at 
all) must act indirectly (likely via Spf1). 
 
Dga1p acts as a catalyst for the Acyl-CoA dependent acylation of diacylglycerol 
(Athenstaedt 2011; Sorger et al 2002) and is responsible for (along with Lro1p) most 
TAG synthesis within the cell (Oelkers et al 2002). Therefore, Dga1p is an essential 
enzyme in lipogenesis, with its deletion causing a significant reduction in neutral lipid 
levels in stationary phase (Figure 3.24) (Athenstaedt, 2011). Upon complementation of 
the dga1 strain with pRS316-DGA1, the neutral lipid phenotype was rescued when 
compared to the control. In the wildtype strain, transformed with pRS316-DGA1, 
neutral lipid levels were similar to the control wildtype strain, containing pRS316 alone. 
Overexpression of DGA1 has been shown to significantly increase neutral lipid 
   1 GATGAGATTA TTGCCTTTAC TGCGCCATTG TCGTGGCAGG ATCATTTCCC TGTCCTCGAT  
  61 AGGCCATCAT CTAGAGTTCA TGTACTGGAA ACTGAGCAAG ACGTGGGATT ACAAACCTAA  
 121 TATGCTTTTC ACATGGTTTA GGTACGCGAT GAGTAAAACC GCGCTAATCC AATGCACGAA  
 181 GATGTTGGCC ATCAAATACC CTGACGTTCT TTGTCTCTCC GTTCATCCGG GTCTGGTGAT  
 241 GAACACAAAC TTATTCAGTT ATTGGACAAG GTTACCCATC GTCGGTATTT TCTTTTGGCT  
 301 GTTGTTCCAG GTCGTAGGGT TCTTTTTCGG CGTATCGAAC GAACAAGGTT CACTAGCTTC  
 361 TTTGAAGTGT GCATTGGACC CGAATTTATC TGTCGAAAAA GATAACGGGA AGTACTTCAC  
 421 CACGGGGGGT AAAGAATCTA AATCGAGCTA CGTTTCTAAC AATGTCGACG AAGCGGCATC  
 481 GACTTGGATC TGGACCGTTC ATCAACTAAG AGACCGTGGT TTCGATATAT AACAAGACGG  
 541 AAAGATTGAA AGAGTAGATA GATGTACATT TTATTTAAAT ATTAGTTAGT CGTTATTGTA  
 601 ACTGGTAATC AGAGCAAGAA GTTTTTCTGT ACTTTGTTCT CTGCAGGCAA CTAAGTTACG  
 661 GGCCGACAAA GGCTTATGAT GTGCGTTTTT TATTCAATTG ATAGATTCAG TCAGCATTGA  
 721 CGTAATGGGA AGGCTAGAAA AAGAGAAGAC TGAATTTGGA AACTTATTCC TCAAAGCAGA  
 781 CCAGTACTTC CACCGCATTT CTGTACTTAA CCAAGCACGA CAGTGGTCTA TCAGGCTTGG  
 841 ATCTTTCACT ACACTTCCGC CAAAGTTTTT TTTTTTTCCT GTTTATCCCA GATCACGTTT  
 901 GTTCCATTAA GGAGGTTTAC TATCATCTCA TTTCCATTTA CACATACACT TACATATACA  
 961 TAAGGAAACG CAGAGGCATA CAGTTTGAAC AGTCACATAA  
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accumulation resulting in S. cerevisiae becoming an oleaginous yeast and 
accumulating lipid up to 45% of cellular mass (Kamisaka et al, 2007), but this was not 
observed in these experiments. This is likely due to the fact that pRS316 is not an over 
expression plasmid (Sikorski et al 1989) and, as DGA1 is under the control of its own 
promoter, limited overexpression would be observed. The expression profile could be 
confirmed using real-time quantitative PCR to determine transcriptional levels (Ponchel 
et al 2003) and, if the protein was tagged, using western blot analysis to determine 
protein levels in the cell (Ghaemmaghami et al 2003).  
 
To determine if Hog1p and Dga1p are on the same pathway, as done with Sch9p, 
neutral lipid levels were measured in single and double delete mutants. Neutral lipid 
accumulation is reduced to a similar level in the hog1Δdga1Δ mutant to that of dga1Δ 
and hog1Δ mutants, when compared to wild type (Figure 3.28). As there is no additive 
effect on neutral lipid levels, this data suggests that Hog1p and Dga1p are on the same 
pathway therefore suggesting Dga1p is a potential downstream target of Hog1p. When 
DGA1 was deleted in combination with pbs2, a reduction in neutral lipid levels was 
observed compared to the wild type. These levels were comparable to the reduction 
seen in the single dga1Δ cells. As the pbs2Δ cells show wildtype levels of neutral lipids, 
this reduction must be the result of loss of Dga1p.   This could be tested by 
reintroducing DGA1, on a plasmid, into pbs2Δ dga1Δ cells and confirming the rescue of 
the neutral lipid phenotype.  
 
If Dga1p is a target of Hog1, its regulation may be direct, or indirect. If interaction is 
direct, then it could be via phosphorylation. Hog1p phosphorylates proteins on a 
conserved sequence, serine or threonine resides followed by a proline residue (S/T P) 
(Roux et al 2004). Therefore, if Dga1p is phosphorylated directly by Hog1p, it should 
contain this amino acid sequence. Figure 3.29 shows four potential MAPK sites 
identified in Dga1. To determine which of these sites are the most likely targets of 
Hog1p, one needs to consider the structure of Dga1 and the position of the potential 
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MAPK sites. For example, if a residue is not accessible to Hog1p then it cannot be 
phosphorylated.  
 
An analysis of the Dga1 protein has produced a topological model of Dga1p as its 
spans the endoplasmic reticular membrane (Liu et al 2011). This model details each 
amino acid, so we can use this model to assess the accessibility of potential MAPK 
phosphorylation sites to Hog1p. The spanning of the ER membrane is show in Figure 
4.3. 
 
Figure 4.3 Proposed topology model of ScDGAT2. This figure shows a proposed 
topological model for Dga1p spanning the ER membrane. The letters represent amino 
acids with the single cysteines being numbered. S17, T53. T84 and S103 are indicated 
on the figure (in red). Taken from Liu et al 2011. 
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Of the four MAPK sites identified, S17 and T53 sites are both on the cytoplasmic side 
of the protein, thus it is possible for them to be phosphorylated by Hog1p. However, 
T84 and S103 are not, with T84 spanning the ER luminal membrane and S103 on the 
inside of the ER. There is no evidence that Hog1p is present in the ER, therefore it is 
unlikely that these sites are phosphorylated by Hog1p. In addition, both S17 and T53 
are in N terminal region of Dga1 that is vital for neutral lipid accumulation, further 
indicating they may be a target for Hog1p (Liu et al 2011). 
  
To determine whether phosphorylation of S17 and T53 was important for activity of the 
Dga1 protein, a mutagenesis strategy was designed to convert these two residues to 
alanine. Mutagenesis of S17 and T53 was attempted using two methods, the 
QuikChange and extended primer method. The QuikChange method copies the entire 
template plasmid and its insert, the primers determining the number of residues to be 
mutated (in this case a point mutation was performed). The wildtype parental plasmid is 
removed by digest with DpnI, a restriction enzyme which digests methylated DNA. Old 
DNA (i.e. parental) will be methylated by E.coli. Newly synthesised DNA via PCR will 
not and therefore will not be digested and so will be the only DNA transformed into 
E.coli. Although successful amplification of the plasmid was determined by agarose gel 
electrophoresis, no E.coli transformants were observed following the DpnI digest, to 
remove the parental plasmid. As the QuikChange method failed the troubleshooting 
guide was consulted. It was possible that although amplification was suggested  by gel 
electrophoresis that the desired plasmid could have been lost following digestion by 
DpnI. It is possible that too little of the intact product was transformed into DH5α E. coli, 
the QuikChange method does not amplify as significantly as regular PCR so following 
DpnI digestion the concentration of plasmid may have been too low to allow for 
successful transformation. This same effect could be due to too low a concentration of 
template, the mutagenesis could be redone with increased concentrations of plasmid 
template as suggested in the troubleshooting guide (e.g. 200ng or 500ng) as the 
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concentration used was ~50ng. The in-house chemically competent E. coli cells may 
not have been sufficiently competent to transform the QuikChange product. Although 
successful with a previous purified plasmid (pRS316DGA1), this is extremely 
concentrated in comparison. The use of highly competent electrocompetent cells may 
have resolved this issue as they are significantly more efficient than chemically 
competent cells (Tu et al 2016). It is also possible that further work was needed to 
better optimise the PCR conditions, the conditions used were that included in the 
manual; 1 minute ignition denaturation at 95oC followed by 30 cycles of 1 minute of 
denaturation at 95oC, 1 minute of annealing at 55oC and 2 minutes of extension time 
per Kb of plasmid at 65oC. Optimisation of the annealing and extension conditions 
(length and temperature) may improve the success of the PCR (Lorenz 2012). The 
extended primer method consisted of 3 reactions (R1 – 3). R1 and R2 utilised a 
TOPODGA1 template using a DGA1 mutagenesis primer (e.g. S17 For) and it’s 
opposing normal DGA1 primer (e.g Dga1 Rev), R1 and R2 utilising the opposite set to 
each other (e.g. R1; S17 For + Dga1 Rev, R2; S17 Rev + Dga1 For). After confirming 
R1 and R2 had worked a gel extraction was performed to purify and concentrate the 
products. R3 utilised normal DGA1 primers (Dga1 For + Dga1 Rev) and used the 
products from R1 and R2 as templates, once amplified this product would be gel 
extracted and transformed into a vector (TOPO and pRS316 were to be attempted). R3 
generated a product for S17 however said product did not successfully clone into a 
TOPO vector, this may be due to the product being of too low a concentration, ideally 
multiple reactions would be combined and gel extracted, however R3 proved to be 
unreliable resulting in little specific R3 product and so a low concentration for cloning. A 
TOPO vector was used as it allows for the easy integration of a gene into a plasmid, 
which then can be transformed into DH5-α E. coli. The TOPO vector had been used 
successfully in this project, with successful insertion of DGA1 into the vector and 
successful transformation into DH5-α E. coli. The first two reactions for the extended 
primer method for S17, T53, T84 and S103 all worked successfully, issues arose with 
the third reaction. It is possible that the PCR reaction for R3 needed to be optimised, 
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however it is also possible that the issue was with the templates used. As the method 
relies upon two templates linking to form product (Heckman et al 2007) it relies even 
more on Brownian motion than a standard PCR. Thus, if the concentration of templates 
was to low then the chances of proper interaction are also lower (Bian et al 2016), 
which may explain the failures seen. The concentration of Mg2+ is also important, the 
standard HF buffer for Phusion used contained 1.5 mM MgCl2, likely each of these 
mutagenesis reactions each needed individual optimisation with regards to Mg2+. 
 
To determine if there is a direct interaction between Hog1p and Dga1, an 
immunoprecipitation (IP) could be performed. Using protein lysates from cells 
undergoing neutral lipid accumulation, Hog1p can be pulled down using a specific 
antibody and tagged Dga1p could then be detected by western blot analysis. This 
method is dependent on obtaining a genomically tagged copy of DGA1 as there are 
currently no antibodies directly against Dga1p. A genomically tagged DGA1 was made 
with a HA tag at the C terminal of the protein, selected with a NAT cassette. This was 
confirmed by PCR using genomic DNA from the yeast clones (Figure 3.30 A - C). 
However, when the PCR positive clones were tested by western blot analysis for 
presence of the C terminal tag, (Figure 3.31) no 3HA tagged Dga1p was observed. To 
determine whether the HA antibody was able to recognise the tag, a positive control 
was included from S.pombe, were atf21 had been genomically tagged with HA. 
Unfortunately, no signal was detected from these samples suggesting that either the 
primary or secondary antibody were not working.   
 
It is also possible that the DGA1 gene, in the phase of growth used for the protein 
extractions, is not transcribed at a high enough level for detection. Alternatively, the 
protein could be rapidly degraded. The samples used were harvested in exponential 
phase, as Dga1p is involved in lipid accumulation and as lipid accumulation occurs in 
stationary phase better results may be seen with stationary phase samples. 
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Introduction of a tagged DGA1 on a normal expression or over expression plasmid 
could be done in a dga1Δ to ensure all expressed DGA1 is tagged. 
 
To test the degradation of Dga1p the proteasome could be inhibited but utilisation of 
CRISPR interference which would utilise an only partially functional Cas9 which would 
bind to the selected gene (which would be selected by the use of a guideRNA) and 
prevent its transcription (Collins et al 2010; Martinez et al 2017). As most proteins are 
degraded in the proteasome, if this is true for Dga1, inhibiting its function would result 
in an increase in Dga1p levels in the cell (Collins et al 2010).  
 
To test the levels of DGA1 transcription a RT-PCR with Syber Green could be used to 
determine mRNA levels (Ponchel et al 2003). If done using cell extractions from 
multiple time points (e.g. 0 – 10 hours with 30-minute time points) one could not only 
see how DGA1 transcription changed as cells begin to accumulate lipid but also with 
the use of an overexpression one could compare levels of transcription between it and 
the wild type. A northern blot could be performed to assess the levels of DGA1 mRNA 
in the cell. This can be done using a radioactive label or a non-radioactive label (e.g. 
biotin, fluorescein, or digoxigenin), with digoxigenin labelled probes having largely 
replaced the others due to having high stability and not having the safety or disposal 
concerns that radioactive labels do (Wu et al 2013). Alternatively, a reverse 
transcription (RT) PCR could also be performed to assess expression levels.  RT-PCR 
detects gene expression through creation of cDNA transcripts from mRNA (Shiao 
2003). The method of RT-PCR described in Shiao 2003, that being, allows for 
quantitative assessment of protein expression.  RT-PCR with Syber Green could also 
be used to determine mRNA levels (Ponchel et al 2003).  
 
To determine if Hog1p is involved with the transcription of DGA1, either directly or 
indirectly though Msn2/4p, ChIP can be used. This method has been used to determine 
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the presence of Hog1p at specific gene promoters under a number of conditions 
(Pascual-Ahuir et al 2006 and Ahuir et al 2006). As such, whether Hog1 is localised to 
the promoter of DGA1 can be determined. Work done previously has utilised a HA 
tagged Hog1p, crosslinked and harvested cells within 5 minutes of stress conditions 
(Pascual-Ahuir et al 2006). Previous work utilised salt stress rather than nutrient 
limitation, so the methodology would require adjustment and optimisation, perhaps 
talking samples over a time course of 30 minute intervals (from mid exponential to 
stationary phase). The methodology using HA tagged Dga1p and Hog1p could be 
attempted and the results compared, it is expected that an interaction with both 
proteins in both experiments would be observed if the two proteins interact directly.  
Observation of DGA1 transcription and protein levels in a hog1Δ mutant would indicate 
an interaction, the methodologies for which have been discussed previously. It would 
be expected that if Hog1p is involved in Dga1p levels that a HOG1 deletion strain 
would transcribe less DGA1 and have less Dga1p in its cells.  
 
If a direct interaction between Hog1p and Dga1p is confirmed, then the mutagenesis 
study of Dga1p determine the role of Hog1p phosphorylation in lipid accumulation. 
Dga1p could be tagged to allow for observation of protein levels and post translational 
modification throughout the lipogenic switch. By extracting and purifying Dga1p its 
phosphorylation state can be determined as was discussed previously for Hog1p 
 
If interaction is indirect then Hog1p could be involved in the transcription of DGA1, 
either by Hog1p itself entering the nucleus and binding the DGA1 promoter, or by with 
Hog1p activating another protein, such as Msn2/4p in the osmotic stress response 
(Hohmann 2002) as discussed previously. Msn4p is involved in the regulation of DGA1 
transcription through the activation of transcription of Spf1p (Hu et al 2007) as 
discussed previously.  
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This work has demonstrated that Hog1p is required for neutral lipid accumulation, 
whereas the upstream elements of the HOG MAPK pathway (Pbs2p, Ste11p and 
Ssk2p) are not. The role of Hog1p appears to be Pbs2p independent, suggesting that 
other proteins may be involved with evidence presented for a role of Sch9p, a kinase. 
Hog1p regulates many cellular processes via downstream targets. In the case of 
neutral lipid accumulation, data has been presented to suggest both Dga1p and 
Msn2/4p are targets of Hog1p, either by direct or direct mechanism.  As such, this 
thesis has presented a novel role of Hog1p in neutral lipid accumulation, which may 
impact on the future development of treatments for cancer lipogenesis. It is possible 
that treatments could be developed that target components of the lipogenesis 
regulatory pathways which go awry in cases of cancer, perhaps utilising technologies 
such as aptamers.  
 
There is also another potential impact, that being biofuel production, generating 
oleaginous yeast from S. cerevisiae has been demonstrated in the literature, by 
genetically modifying S. cerevisiae (with the intent of altering the lipogenic nature of the 
cell though the Hog1 MAPK and its interacting pathways) it may be possible to 
generate a mutant S. cerevisiae strain that is ideal for biofuel production. S. 
cerevisiae’s well characterised nature combined with its already extensive use by 
industry would likely allow for a much easier start-up of a S. cerevisiae based biofuel 
industry (what with all the fermentation work done with its involvement in alcohol 
production) relative to that of some other oleaginous yeast such as Lipomyces starkeyi. 
 
5.0 Appendix 
5.1 Appendix 1 – Sequencing data from Source Bioscience  
 
To determine if DGA1 was successfully integrated into its vector it was sequenced. To 
determine if the sequence was as expected DGA1 was located within the sequence 
data and compared via NCBI blast to a known sequence of DGA1 (in this case from the 
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saccharomyces genome database). 
 
NCBI BLAST – DGA1 SEQ 
 
Query  1     ATGTCAGGAACATTCAATGATATaagaagaaggaagaaggaagaaggaagCCCTACAGCC  60 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1     ATGTCAGGAACATTCAATGATATAAGAAGAAGGAAGAAGGAAGAAGGAAGCCCTACAGCC  60 
 
Query  61    GGTATTACCGAAAGGCATGAGAATAAGTCTTTGTCAAGCATCGATAAAAGAGAACAGACT  120 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  61    GGTATTACCGAAAGGCATGAGAATAAGTCTTTGTCAAGCATCGATAAAAGAGAACAGACT  120 
 
Query  121   CTCAAACCACAACTAGAGTCATGCTGTCCATTGGCGACCCCTTTTGAAAGAAGGTTACAA  180 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  121   CTCAAACCACAACTAGAGTCATGCTGTCCATTGGCGACCCCTTTTGAAAGAAGGTTACAA  180 
 
Query  181   ACTCTGGCTGTAGCATGGCACACTTCTTCATTTGTACTCTTCTCCATATTTACGTTATTT  240 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  181   ACTCTGGCTGTAGCATGGCACACTTCTTCATTTGTACTCTTCTCCATATTTACGTTATTT  240 
 
Query  241   GCAATCTCGACACCAGCACTGTGGGTTCTTGCTATTCCATATATGATTTAtttttttttC  300 
             |||||||||||||||||||||||||||||||||||||||||||||||||| ||||||||| 
Sbjct  241   GCAATCTCGACACCAGCACTGTGGGTTCTTGCTATTCCATATATGATTTA-TTTTTTTTC  299 
 
Query  301   GATAGGTCTCCTGCAACTGGCGAAGTGGTAAATCGATACTCTCTTCGATTTCGTTCATTG  360 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  300   GATAGGTCTCCTGCAACTGGCGAAGTGGTAAATCGATACTCTCTTCGATTTCGTTCATTG  359 
 
Query  361   CCCATTTGGAAGTGGTATTGTGATTATTTCCCTATAAGTTTGATTAAAACTGTCAATTTA  420 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  360   CCCATTTGGAAGTGGTATTGTGATTATTTCCCTATAAGTTTGATTAAAACTGTCAATTTA  419 
 
Query  421   AAACCAACTTTTACGCTTTCAAAAAATAAGAGAGTTAACGaaaaaaaTTACAAGATTAGA  480 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  420   AAACCAACTTTTACGCTTTCAAAAAATAAGAGAGTTAACGAAAAAAATTACAAGATTAGA  479 
 
Query  481   TTGTGGCCAACTAAGTATTCCATTAATCTCAAAAGCAACTCTACTATTGACTATCGCAAC  540 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  480   TTGTGGCCAACTAAGTATTCCATTAATCTCAAAAGCAACTCTACTATTGACTATCGCAAC  539 
 
Query  541   CAGGAATGTACAGGGCCAACGTACTTATTTGGTTACCATCCACACGGCATAGGAGCACTT  600 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  540   CAGGAATGTACAGGGCCAACGTACTTATTTGGTTACCATCCACACGGCATAGGAGCACTT  599 
111 
 
 
Query  601   GGTGCGTTTGGAGCGTTTGCAACAGAAGGTTGTAACTATTCCAAGATTTTCCCAGGTATT  660 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  600   GGTGCGTTTGGAGCGTTTGCAACAGAAGGTTGTAACTATTCCAAGATTTTCCCAGGTATT  659 
 
Query  661   CCTATTTCTCTGATGACACTGGTCACACAATTTCATATCCCATTGTATAGAGACTACTTA  720 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  660   CCTATTTCTCTGATGACACTGGTCACACAATTTCATATCCCATTGTATAGAGACTACTTA  719 
 
Query  721   TTGGCGTTAGGTATTTCTTCAGTATCTCGGAAAAACGCTTTAAGGACTCTAAGCAAAAAT  780 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  720   TTGGCGTTAGGTATTTCTTCAGTATCTCGGAAAAACGCTTTAAGGACTCTAAGCAAAAAT  779 
 
Query  781   CAGTCGATCTGCATTGTTGTTGGTGGCGCTAGGGAATCTTTATTAAGTTCAACAAATGGT  840 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  780   CAGTCGATCTGCATTGTTGTTGGTGGCGCTAGGGAATCTTTATTAAGTTCAACAAATGGT  839 
 
Query  841   ACACAACTGATTTTAAACAAAAGAAAGGGTTTTATTAAACTGGCCATTCAAACGGGGAAT  900 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  840   ACACAACTGATTTTAAACAAAAGAAAGGGTTTTATTAAACTGGCCATTCAAACGGGGAAT  899 
 
Query  901   ATTAACCTAGTGCCTGTGTTTGCATTTGGAGAGGTGGACTGTTATAATGTTCTGAGCACa  960 
             ||||||||||||||||||||||||||||||  |||||||||||||||||||||||||||| 
Sbjct  900   ATTAACCTAGTGCCTGTGTTTGCATTTGGANNGGTGGACTGTTATAATGTTCTGAGCACA  959 
 
Query  961   aaaaaaGATTCAGTCCTGGGTAAAATGCAACTATGGTTCAAAGAAAACTTTGGTTTTACC  
1020 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  960   AAAAAAGATTCAGTCCTGGGTAAAATGCAACTATGGTTCAAAGAAAACTTTGGTTTTACC  
1019 
 
Query  1021  ATTCCCATTTTCTACGCAAGAGGATTATTCAATTACGATTTCGGTTTGTTGCCATTTAGA  
1080 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||| ||| 
Sbjct  1020  ATTCCCATTTTCTACGCAAGAGGATTATTCAATTACGATTTCGGTTTGTTGCCATTNAGA  
1079 
 
Query  1081  GCGCCTATCAATGTTGTTGTTGGAAGGCCTATATACGTTGAAAAGAAAATAACAAATCCG  
1140 
               |||||||||||||||||||||||||||||||||| ||||||||||||||||||||||  
Sbjct  1080  NNGCCTATCAATGTTGTTGTTGGAAGGCCTATATACNTTGAAAAGAAAATAACAAATCCN  
1139 
 
Query  1141  CCAGA-TGATGTTGTTAATCATTTCCATGA-TTT  1172 
             ||  | |||||||||||||||||||||||| ||| 
Sbjct  1140  CCNAANTGATGTTGTTAATCATTTCCATGAATTT  1173 
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